Title of Invention

METHOD FOR THE PRODUCTION OF 3-PHENYL(THIO)URACILS AND DITHIOURACILS

Abstract The instant invention discloses a process for preparing 3-phenyl(thio)uracils and - dithiouracils of the formula I where the variables are each defined as follows: R1 is hydrogen, C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyI, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6- haloalkynyl, phenyl-C1-C4-alkyl or amino, R2 and R3 are each independently hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl or C3-C6-haloalkynyl; X1, X2 and X3 are each independently oxygen or sulfur; Ar is phenyl which may be partly or fully halogenated and/or may carry from one to three radicals from the group of cyano, C1-C4-alkyl or C1-C4-haloalkyl, and A is NR4R5 where R4 and R5 are each independently hydrogen or C1-C6-alkyl; which comprises reacting carbamates of the formula II where the variables X1, X3, Ar and A are each as defined above and L1 is C1-C6-alkoxy or C1-C6-alkylthio with enamines of the formula III where the variables X2, R1, R2 and R3 are each as defined above and L2 is C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy, C1-C4-alkylthio-C2C4-alkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyl-oxy, C3-C6-alkynyloxy, C3-C6-haloalkynyloxy, C3-C8-cycloalkyloxy, C1-C6-cyanoalkoxy or benzyloxy which in turn may be partially or fully halogenated on the phenyl ring and/or may be substituted by from one to three radicals from the group of cyano, nitro, C1-C4-alkyl, C1- C4-alkoxy and C1-C4-alkylthio; in the presence of an excess of base, such as herein described based on the carbamate of the formula II.
Full Text Method for the production of 3-phenyl(thio)uracils and dithiouracils
Description
The present invention relates to a process for preparing 3-phenyl(thio)uracils and
-dithiouracils of the formula I

where the variables are each defined as follows:
R1 is hydrogen, C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl,
C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl, phenyl-C1-C4-
alkyl or amino,
R2 and R3 are each independently
hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-
haloalkenyl, C3-C6-alkynyl or C3-C6-haloalkynyl;
X1, X2 and X3 are each independently
oxygen or sulfur;
Ar is phenyl which may be partly or fully halogenated and/or may carry from one to
three radicals from the group of cyano, C1-C4-alkyl or C1-C4-haloalkyl, and
A is a radical derived from a primary or secondary amine or NH2.
Phenyluracils which carry, in the meta-position to the uracil ring on the phenyl ring, a
heterocycle or an unsaturated ester, thioester or amide radical which is attached to the
phenyl ring via an oxygen or sulfur atom are known from WO 04/056785.
3-Phenyluracils of the general formula I and the corresponding thio- and dithiouracils
are known in principle from WO 01/83459.
They are prepared in accordance with the teaching given in WO 01/83459 by the
following methods A to C.
In the following schemes A to C, the variables Ar and A each have the definitions
specified above among others, Hal is halogen and Q is an optionally substituted
heterocycle:
, Method A:
Condensation of a substituted benzoic acid with a substituted sulfuric diamide in the
presence of N,N-carbonyldiimidazole (CDI) or conversion of the carboxylic acid to its
acid chloride and subsequent reaction of the acid chloride with a sulfuric diamide
according to the following scheme A:

A disadvantage of this procedure is that the benzoic acid used is only obtainable from
the precursor ester by cleavage using boron tribromide with corresponding salt
formation. In addition, the yield of the condensation with sulfuric diamides is only
between 16 and 45%. The detour via an acid chloride prepared beforehand also leads
in only 26% yield to the desired benzoylsulfuric diamide.
Method B:
Replacement of a halogen atom with a uracil, thiouracil or dithiouracil radical according
to the following scheme B:

The method B has the disadvantage that the haloaromatic used first has to be
prepared in a complicated manner by a Sandmeyer reaction. In addition, the selectivity
of the reaction with respect to the halogen radical is unsatisfactory when further
halogen substituents are present on Ar.
Method C:
Reaction of aniline compound with an oxazinone and subsequent alkylation of the
resulting 3-phenyluracil in the presence of a base according to the following scheme C:

It is disadvantageous that the oxazinone used first has to be prepared in a complicated
manner by reacting an aminocrotonic ester with a dialkylcarbamoyl chloride and
subsequently cyclizing with phosphorus oxychloride, phosphorus pentachloride or
oxalyl chloride. This process is likewise not sufficiently economically viable owing to the
starting materials used and the reaction stages.
1 It is therefore an object of the present invention to provide a process for preparing 3-
phenyl(thio)uracils and -dithiouracils of the formula I which affords the 3-
phenyl(thio)uracils and -dithiouracils of the formula I in high yields and good purity, and
additionally overcomes the outlined disadvantages of the prior art.
It is a further object of the present invention to provide a simple and easy-to-handle
process for preparing carbamates of the formula II, which affords the carbamates of the
formula II in high yields and good purity.
It is a further object of the present invention to provide a process for preparing 3-
phenyl(thio)uracils and -dithiouracils of the formula I, which additionally comprises the
process for preparing the carbamates of the formula II.
It has been found that, surprisingly, this object is achieved by a process in which the
carbamates of the formula II

where the variables X1, X3, Ar and A are each as defined above and
L1 is a nucleophilically displaceable leaving group;
are reacted with enamines of the formula III

where the variables X2, R1, R2 and R3 are each as defined above and
L2 is a nucleophilically displaceable leaving group.
The present invention therefore provides a process for preparing the above-defined 3-
phenyl(thio)uracils and -dithiouracils of the formula I, comprising the reaction of
carbamates of the formula II with an enamine of the formula III.
The carbamates of the formula II may themselves be prepared in analogy to the prior
art processes (for example Houben-Weyl, Methoden der organischen Chemie
Methods of organic chemistry], E5, 1985, p. 972-980, and also VIII, p. 655 and XI
part 2, p. 10; J. B. Press et al, J. Het. Chem., 23, 6, 1986, p. 1821-1828; I. Vanthey et
al., Tetrahedron Lett. 41, 33, 2000, p. 6347-6350; M. Belley et al., Synlett, 2, 2001,
p. 222-225) from amines of the formula IV

where X3, Ar and A are each as defined above by reacting with a compound of the
formula V
where X1 and L1 are each as defined above and L3 is a nucleophilically displaceable
leaving group.
Accordingly the process.according to the invention preferably comprises the provision
of the carbamates of the formula II by this route.
The carbamates of the formula II are novel and likewise form part of the subject matter
•'of the present invention as starting materials or intermediates in the process according
to the invention.
The organic molecular moieties specified in the definition of the substituents R1-R3, Ar
and A or as radicals on phenyl rings constitute, like the definition halogen, collective
terms for individual lists of the individual group members, the expression Cn-Cm
specifying the possible number of the carbon atoms in the molecular moiety. All
hydrocarbon chains, i.e. all alkyl, haloalkyl, cyanoalkyl, cyanoalkoxy, alkoxy,
haloalkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, dialkylamino, alkylcarbonyl,
alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkenyl, haloalkenyl,
alkenyloxy, haloalkenyloxy, alkynyl, haloalkynyl, alkynyloxy, haloalkynyloxy,
alkoxyalkoxy and alkylthioalkoxy moieties, may be straight-chain or branched. Unless
stated otherwise, halogenated substituents carry preferably from one to five identical or
different halogen atoms. The definition halogen is in each case fluorine, chlorine,
bromine or iodine.
Examples of definitions include:
- C1-C4alkyl: for example methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,
1-methylpropyl, 2-methylpropyl and 1,1-dimethylethyl;
- C1-C6-alkyl: C1-C4-alkyl as specified above, and also, for example, n-pentyl,
1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl,
n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl,
3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl,
1,3-di-methylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl,
1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-
3-methyl propyl;
- CrC^alkylcarbonyl: for example methylcarbonyl, ethylcarbonyl, propylcarbonyl,
1-methylethylcarbonyl, butylcarbonyl, 1-methylpropylcarbonyl, 2-methylpropyl-
carbonyl or 1,1-dimethylethylcarbonyl;
- C3-C8-cycloalkyl and the cycloalkyl moieties of C3-C8-cycloalkoxy: for example
cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl;
- C3-C8-cycloalkenyl: for example cyclopropen1-yl, cyclopropen-2-yl, cyclobuten-1-yl,
cyclobuten-2-yl, cyclopenten-1-yl, cyclopent-2-en-1-yl, cyclopent-2,4-dien-1-yl,
cyclohexen-1-yl, cyclohex-2-en-1-yl, cyclohex-3-en-1-yl; cyclohepten-1-yl,
cyclohept-2-en-1-yl, cyclohept-3-en-1-yl, cycloocten-1-yl, cyclooct-2-en-1-yl,
cyclooct-3-en-1-yl, cyclooct-4-en-1-yl;
- 3- to 6-membered heterocyclyl: a saturated, partially unsaturated or aromatic 3-, 4-,
5- or 6-membered heterocyclic ring which comprises from one to four identical or
different heteroatoms selected from the group of oxygen, sulfur, nitrogen or the
NR6 group (where R6 is hydrogen, C1-C6-alkyl, C3-C6-alkenyl or C3-C6-alkynyl), may
if appropriate have one or two carbonyl groups or thiocarbonyl groups as ring
members and may be bonded via C or N:
for example 2-oxrianyl, 2-oxetanyl, 3-oxetanyl, 2-aziridinyl, 3-thiethanyl, 1-
azetidinyl, 2-azetidinyl,
for example tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl,
tetrahydrothien-3-yl, tetrahydropyrrol-2-yl, tetrahydropyrrol-3-yl, tetrahydropyrazol-
3-yl, tetrahydropyrazol-4-yl, tetrahydroisoxazol-3-yl, tetrahydroisoxazol-4-yl,
tetrahydroisoxazol-5-yl, 1,2-oxathiolan-3-yl, 1,2-oxathiolan-4-yl, 1,2-oxathiolan-5-yl,
tetrahydroisothiazol-3-yl, tetrahydroisothiazol-4-yl, tetrahydroisothiazol-5-yl,
1,2-dithiolan-3-yl, 1,2-dithiolan-4-yl, tetrahydroimidazol-2-yl, tetrahydroimidazol-
4-yl, tetrahydrooxazol-2-yl, tetrahydrooxazol-4-yl, tetrahydrooxazol-5-yl,
tetrahydrothiazol-2-yl, tetrahydrothiazol-4-yl, tetrahydrothiazol-5-yl, 1,3-dioxolan-
2-yl, 1,3-dioxolan-4-yl, 1,3-oxathiolan-2-yl, 1,3-oxathiolan-4-yl, 1,3-oxathiolan-5-yl,
1,3-dithiolan-2-yl, 1,3-dithiolan-4-yl, 1,3,2-dioxathiolan-4-yl;
for example tetrahydropyrrol-1-yl, tetrahydropyrazol-1-yl, tetrahydroisoxazol-2-yl,
tetrahydroisothiazol-2-yl, tetrahydroimidazol-1-yl, tetrahydrooxazol-3-yl,
tetra hyd roth i azo l-3-y I;
for example 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl,
2,5-dihydrofuran-3-yl, 4,5-dihydrofuran-2-yl, 4,5-dihydrofuran-3-yl, 2,3-dihydrothien-
2-yl, 2,3-dihydrothien-3-yl, 2,5-dihydrothien-2-yl, 2,5-dihydrothien-3-yl,
4,5-dihydrothien-2-yl, 4,5-dihydrothien-3-yl, 2,3-dihydro-1H-pyrrol-2-yl, 2,3-dihydro-
1H-pyrrol-3-yl, 2,5-dihydro-1H-pyrrol-2-yl, 2,5-dihydro-1H-pyrrol-3-yl, 4,5-dihydro-
1H-pyrrol-2-yl, 4,5-dihydro-1H-pyrrol-3-yl, 3,4-dihydro-2H-pyrrol-2-yl, 3,4-dihydro-
2H-pyrrol-3-yl, 3,4-dihydro-5H-pyrrol-2-yl, 3,4-dihydro-5H-pyrrol-3-yl, 4,5-dihydro-
1 H-pyrazol-3-yl, 4,5-dihydro-1 H-pyrazol-4-yl, 4,5-dihydro-1 H-pyrazol-5-yl,
2,5-dihydro-1 H-pyrazol-3-yl, 2,5-dihydro-1 H-pyrazol-4-yl, 2,5-dihydro-1 H-pyrazol-
5-yl, 4,5-dihydroisoxazol-3-yl, 4,5-dihydroisoxazol-4-yl, 4,5-dihydroisoxazol-5-yl,
2,5-dihydroisoxazol-3-yl, 2,5-dihydroisoxazol-4-yl, 2,5-dihydroisoxazol-5-yl,
2,3-dihydroisoxazol-3-yl, 2,3-dihydroisoxazol-4-yl, 2,3-dihydroisoxazol-5-yl,
4,5-dihydroisothiazol-3-yl, 4,5-dihydroisothiazol-4-yl, 4,5-dihydroisothiazol-5-yl,
2,5-dihydroisothiazol-3-yl, 2,5-dihydroisothiazol-4-yl, 2,5-dihydroisothiazol-5-yl,
2,3-dihydroisothiazol-3-yl, 2,3-dihydroisothiazol-4-yl, 2,3-dihydroisothiazol-5-yl,
A3-1,2-dithiol-3-yl, A3-1,2-dithiol-4-yl, A3-1,2-dithiol-5-yl, 4,5-dihydro-1H-imidazol-
2-yl, 4,5-dihydro-1H-imidazol-4-yl, 4,5-dihydro-1H-imidazol-5-yl, 2,5-dihydro-
1 H-imidazol-2-yl, 2,5-dihydro-1 H-imidazol-4-yl, 2,5-dihydro-1 H-imidazol-5-yl,
2,3-dihydro-1 H-imidazol-2-yl, 2,3-dihydro-1 H-imidazol-4-yl, 4,5-dihydrooxazol-2-yl,
4,5-dihydrooxazol-4-yl, 4,5-dihydrooxazol-5-yl, 2,5-dihydrooxazol-2-yl,
2,5-dihydrooxazol-4-yl, 2,5-dihydrooxazol-5-yl, 2,3-dihydro-oxazol-2-yl,
2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 4,5-dihydrothiazol-2-yi,
4,5-dihydrothiazol-4-yl, 4,5-dihydrothiazol-5-yl, 2,5-dihydrothiazol-2-yl,
2,5-dihydrothiazol-4-yl, 2,5-dihydrothiazol-5-yl, 2,3-dihydrothiazol-2-yl,
2,3-dihydrothiazol-4-yl, 2,3-dihydrothiazol-5-yl, 1,3-dioxol-2-yI, 1,3-dioxol-4-yl,
1,3-dithiol-2-yl, 1,3-dithiol-4-yl, 1,3-oxathiol-2-yl, 1,3-oxathiol-4-yl, 1,3-oxathiol-5-yl,
1,2,3-A2-oxadiazolin-4-yl, 1,2,3-A2-oxadiazolin-5-yl, 1,2,4-A4-oxadiazolin-3-yl,
1,2,4-A4-oxadiazolin-5-yl, 1,2,4-A2-oxadiazolin-3-yl, 1,2,4-A2-oxadiazolin-5-yl,
1,2,4-A3-oxadiazolin-3-yl, 1,2,4-A3-oxadiazolin-5-yl, 1,3,4-A2-oxadiazolin-2-yl,
1,3,4-A2-oxadiazolin-5-yl, 1,3,4-A3-oxadiazolin-2-yl, 1,3,4-oxadiazolin-2-yl,
1,2,4-A4-thiadiazolin-3-yl, 1,2,4-A4-thiadiazolin-5-yl, 1,2,4-A3-thiadiazolin-3-yl,
1,2,4-A3-thiadiazolin-5-yl, 1,2,4-A2-thiadiazolin-3-yl, 1,2,4-A2-thiadiazolin-5-yl,
1,3,4-A2-thiadiazolin-2-yl, 1,3,4-A2-thiadiazolin-5-yl, 1,3,4-A3-thiadiazolin-2-yl,
1,3,4-thiadiazolin-2-yl, 1,2,3-A2-triazolin-4-yl, 1,2,3-A2-triazolin-5-yl,
1,2,4-A2-triazolin-3-yl, 1,2,4-A2-triazolin-5-yl, 1,2,4-A3-triazolin-3-yl,
1,2,4-A3-triazolin-5-yl, 1,2,4-A1-triazolin-2-yl, 1,2,4-triazolin-3-yl, 3H-1,2,4-dithiazol-
5-yl, 2H-1,3,4-dithiazol-5-yl, 2H-1,3,4-oxathiazol-5-yl;
for example 2,3-dihydro-1H-pyrrol-1-yl, 2,5-dihydro-1H-pyrrol-1-yl, 4,5-dihydro-
1 H-pyrazol-1-yl, 2,5-dihydro-1 H-pyrazol-1-yl, 2,3-dihydro-1 H-pyrazol-1-yl,
2,5-dihydroisoxazol-2-yl, 2,3-dihydroisoxazol-2-yl, 2,5-dihydroisothiazol-2-yl,
2,3-dihydroisoxazol-2-yl, 4,5-dihydro-1 H-imidazol-1-yl, 2,5-dihydro-1 H-imidazol-
1-yl, 2,3-dihydro-1H-imidazol-1-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrothiazol-3-yl,
1,2,4-A4-oxadiazolin-2-yl, 1,2,4-A2-oxadiazolin-4-yl, 1,2,4-A3-oxadiazolin-2-yl,
1,3,4-A2-oxadiazolin-4-yl, 1,2,4-A5-thiadiazolin-2-yl, 1,2,4-A3-thiadiazolin-2-yl,
1,2,4-A2-thiadiazolin-4-yl, 1,3,4-A2-thiadiazolin-4-yl, 1,2,3-A2-triazolin-1-yl,
1,2,4-A2-triazolin-1-yl, 1,2,4-A2-triazolin-4-yl, 1,2,4-A3-triazolin-1-yl,
1,2,4-A1-triazolin-4-yl;
for example 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, pyrrol-2-yl, pyrrol-3-yl, pyrazol-3-yl,
pyrazol-4-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, isothiazol-3-yl, isothiazol-
4-yl, isothiazol-5-yl, imidazol-2-yl, imidazol-4-yl, oxazol-2-yl, oxazol-4-yl, oxazol-
5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, 1,2,3-oxadiazol-4-yl, 1,2,3-oxadiazol-5-yl,
1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,3-thiadiazol-
4-yl, 1,2,3-thiadiazol-5-yl, 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl,
1,3,4-thiadiazol-2-yl, 1,2,3-triazol-4-yl, 1,2,4-triazol-3-yl, tetrazol-5-yl;
for example pyrrol-1-yl, pyrazol-1-yl, imidazol-1-yl, 1,2,3-triazol-1-yl, 1,2,4-triazol-1-
yl, tetrazol-1-yl;
for example tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl,
piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, tetrahydrothiopyran-2-yl,
tetrahydrothiopyran-3-yl, tetrahydrothiopyran-4-yl, 1,3-dioxan-2-yl, 1,3-dioxan-4-yl,
1,3-dioxan-5-yl, 1,4-dioxan-2-yl, 1,3-dithian-2-yl, 1,3-dithian-4-yl, 1,3-dithian-5-yl,
1,4-dithian-2-yl, 1,3-oxathian-2-yl, 1,3-oxathian-4-yl, 1,3-oxathian-5-yl,
1,3-oxathian-6-yl, 1,4-oxathian-2-yl, 1,4-oxathian-3-yl, 1,2-dithian-3-yl, 1,2-dithian-
4-yl, hexahydropyrimidin-2-yl, hexahydropyrimidin-4-yl, hexahydropyrimidin-5-yl,
hexahydropyrazin-2-yl, hexahydropyridazin-3-yl, hexahydropyridazin-4-yl,
tetrahydro-1,3-oxazin-2-yl, tetrahydro-1,3-oxazin-4-yl, tetrahydro-1,3-oxazin-5-yl,
tetrahydro-1,3-oxazin-6-yl, tetrahydro-1,3-thiazin-2-yl, tetrahydro-1,3-thiazin-4-yl,
tetrahydro-1,3-thiazin-5-yl, tetrahydro-1,3-thiazin-6-yl, tetrahydro-1,4-thiazin-2-yl,
tetrahydro-1,4-thiazin-3-yl, tetrahydro-1,4-oxazin-2-yl, tetrahydro-1,4-oxazin-3-yl,
tetrahydro-1,2-oxazin-3-yl, tetrahydro-1,2-oxazin-4-yl, tetrahydro-1,2-oxazin-5-yl,
tetrahydro-1,2-oxazin-6-yl;
for example piperidin-1-yl, hexahydropyrimidin-1-yl, hexahydropyrazin-1-yl,
hexahydropyridazin-1-yl, tetrahydro-1,3-oxazin-3-yl, tetrahydro-1,3-thiazin-3-yl,
tetrahydro-1,4-thiazin-4-yl, tetrahydro-1,4-oxazin-4-yl, tetrahydro-1,2-oxazin-2-yl;
for example 2H-3,4-dihydropyran-6-yl, 2H-3,4-dihydropyran-5-yl, 2H-3.4-
dihydropyran-4-yl, 2H-3,4-dihydropyran-3-yI, 2H-3,4-dihydropyran-2-yl, 2H-3.4-
dihydropyran-6-yl, 2H-3,4-dihydrothiopyran-5-yl, 2H-3,4-dihydrothiopyran-4-yl, 2H-
3,4-dihydropyran-3-yl, 2H-3,4-dihydropyran-2-yl, 1,2,3,4-tetrahydropyridin-6-yl,
1,2,3,4-tetrahydropyridin-5-yl, 1,2,3,4-tetrahydropyridin-4-yl, 1,2,3,4-
tetrahydropyridin-3-yl, 1,2,3,4-tetrahydropyridin-2-yl, 2H-5,6-dihydropyran-2-yl, 2H-
5,6-dihydropyran-3-yl, 2H-5,6-dihydropyran-4-yl, 2H-5,6-dihydropyran-5-yl, 2H-5,6-
dihydropyran-6-yl, 2H-5,6-dihydrothiopyran-2-yl, 2H-5,6-dihydrothiopyran-3-yl, 2H-
5,6-dihydrothiopyran-4-yl, 2H-5,6-dihydrothiopyran-5-yl, 2H-5,6-dihydrothiopyran-6-
yl, 1,2,5,6-tetrahydropyridin-2-yl, 1,2,5,6-tetrahydropyridin-3-yl, 1,2,5,6-
tetrahydropyridin-4-yl, 1,2,5,6-tetrahydropyridin-5-yl, 1,2,5,6-tetrahydropyridin-6-yl,
2,3,4,5-tetrahydropyridin-2-yl,2,3,4,5-tetrahydropyridin-3-yl, 2,3,4,5-
tetrahydropyridin-4-yl, 2,3,4,5-tetrahydropyridin-5-yl, 2,3,4,5-tetrahydropyridin-6-yl,
4H-pyran-2-yl, 4H-pyran-3-yl, 4H-pyran-4-yl, 4H-thiopyran-2-yl, 4H-thiopyran-3-yl,
4H-thiopyran-4-yl, 1,4-dihydropyridin-2-yl, 1,4-dihydropyridin-3-yl, 1,4-
dihydropyridin-4-yl, 2H-pyran-2-yl, 2H-pyran-3-yl, 2H-pyran-4-yl, 2H-pyran-5-yl, 2H-
pyran-6-yl, 2H-thiopyran-2-yl, 2H-thiopyran-3-yl, 2H-thiopyran-4-yl, 2H-thiopyran-5-
yl, 2H-thiopyran-6-yl, 1,2-dihydropyridin-2-yl, 1,2-dihydropyridin-3-yl, 1,2-dihydro-
pyridin-4-yl, 1,2-dihydropyridin-5-yl, 1,2-dihydropyridin-6-yl, 3,4-dihydropyridin-2-yl,
3,4-dihydropyridin-3-yl, 3,4-dihydropyridin-4-yl, 3,4-dihydropyridin-5-yl, 3,4-
dihydropyridin-6-yl, 2,5-dihydropyridin-2-yl, 2,5-dihydropyridin-3-yl, 2,5-
dihydropyridin-4-yl, 2,5-dihydropyridin-5-yl, 2,5-dihydropyridin-6-yl, 2,3-
dihydropyridin-2-yl, 2,3-dihydropyridin-3-yl, 2,3-dihydropyridin-4-yl, 2,3-
dihydropyridin-5-yl, 2,3-dihydropyridin-6-yl, 2H-5,6-dihydro-1,2-oxazin-3-yl, 2H-5.6-
dihydro-1,2-oxazin-4-yl, 2H-5,6-dihydro-1,2-oxazin-5-yl, 2H-5,6-dihydro-1,2-oxazin-
6-yl, 2H-5,6-dihydro-1,2-thiazin-3-yl, 2H-5,6-dihydro-1,2-thiazin-4-yl, 2H-5.6-
dihydro-1,2-thiazin-5-yl, 2H-5,6-dihydro-1,2-thiazin-6-yl, 4H-5,6-dihydro-1,2-oxazin-
3-yl, 4H-5,6-dihydro-1,2-oxazin-4-yl, 4H-5,6-dihydro-1,2-oxazin-5-yl, 4H-5.6-
dihydro-1,2-oxazin-6-yl, 4H-5,6-dihydro-1,2-thiazin-3-yl, 4H-5,6-dihydro-1,2-thiazin-
4-yl, 4H-5,6-dihydro-1,2-thiazin-5-yl, 4H-5,6-dihydro-1,2-thiazin-6-yl, 2H-3.6-
dihydro-1,2-oxazin-3-yl, 2H-3,6-dihydro-1,2-oxazin-4-yl, 2H-3,6-dihydro-1,2-oxazin-
5-yl, 2H-3,6-dihydro-1,2-oxazin-6-yl, 2H-3,6-dihydro-1,2-thiazin-3-yl, 2H-3.6-
dihydro-1,2-thiazin-4-yi, 2H-3,6-dihydro-1,2-thiazin-5-yl, 2H-3,6-dihydro-1,2-thiazin-
6-yl, 2H-3,4-dihydro-1,2-oxazin-3-yl, 2H-3,4-dihydro-1,2-oxazin-4-yl, 2H-3.4-
dihydro-1,2-oxazin-5-yl, 2H-3,4-dihydro-1,2-oxazin-6-yl, 2H-3,4-dihydro-1,2-thiazin-
3-yl, 2H-3,4-dihydro-1,2-thiazin-4-yl, 2H-3,4-dihydro-1,2-thiazin-5-yl, 2H-3.4-
dihydro-1,2-thiazin-6-yl, 2,3,4,5-tetrahydropyridazin-3-yl, 2,3,4,5-tetrahydro-
pyridazin-4-yl, 2,3,4,5-tetrahydropyridazin-5-yl, 2,3,4,5-tetrahydropyridazin-6-yl,
3,4,5,6-tetrahydropyridazin-3-yl, 3,4,5,6-tetrahydropyridazin-4-yl, 1,2,5,6-
tetrahydropyridazin-3-yl, 1,2,5,6-tetrahydropyridazin-4-yl, 1,2,5,6-tetrahydro-
pyridazin-5-yl, 1,2,5,6-tetrahydropyridazin-6-yl, 1,2,3,6-tetrahydropyridazin-3-yl,
1,2,3,6-tetrahydropyridazin-4-yl, 4H-5,6-dihydro-1,3-oxazin-2-yl, 4H-5,6-dihydro-
1,3-oxazin-4-yl, 4H-5,6-dihydro-1,3-oxazin-5-yl, 4H-5,6-dihydro-1,3-oxazin-6-yl, 4H-
5,6-dihydro-1,3-thiazin-2-yl, 4H-5,6-dihydro-1,3-thiazin-4-yl, 4H-5,6-dihydro-1,3-
thiazin-5-yl, 4H-5,6-dihydro-1,3-thiazin-6-yl, 3,4,5,6-tetrahydropyrimidin-2-yl,
3,4,5,6-tetrahydropyrimidin-4-yl, 3,4,5,6-tetrahydropyrimidin-5-yl, 3,4,5,6-
tetrahydropyrimidin-6-yl, 1,2,3,4-tetrahydropyrazin-2-yl, 1,2,3,4-tetrahydropyrazin-
5-yl, 1,2,3,4-tetrahydropyrimidin-2-yl, 1,2,3,4-tetrahydropyrimidin-4-yl, 1,2,3,4-
tetrahydropyrimidin-5-yl, 1,2,3,4-tetrahydropyrimidin-6-yl, 2,3-dihydro-1,4-thiazin-2-
yl, 2,3-dihydro-1,4-thiazin-3-yl, 2,3-dihydro-1,4-thiazin-5-yl, 2,3-dihydro-1,4-thiazin-
6-yl, 2H-1,2-oxazin-3-yl, 2H-1,2-oxazin-4-yl, 2H-1,2-oxazin-5-yl, 2H-1,2-oxazin-6-yl,
2H-1,2-thiazin-3-yl, 2H-1,2-thiazin-4-yl, 2H-1,2-thiazin-5-yl, 2H-1,2-thiazin-6-yl, 4H-
1,2-oxazin-3-yl, 4H-1,2-oxazin-4-yl, 4H-1,2-oxazin-5-yl, 4H-1,2-oxazin-6-yl, 4H-1.2-
thiazin-3-yl, 4H-1,2-thiazin-4-yl, 4H-1,2-thiazin-5-yl, 4H-1,2-thiazin-6-yl, 6H-1.2-
oxazin-3-yl, 6H-1,2-oxazin-4-yI, 6H-1,2-oxazin-5-yl, 6H-1,2-oxazin-6-yl, 6H-1.2-
thiazin-3-yl, 6H-1,2-thiazin-4-yl, 6H-1,2-thiazin-5-yl, 6H-1,2-thiazin-6-yl, 2H-1.3-
oxazin-2-yl, 2H-1,3-oxazin-4-yi, 2H-1,3-oxazin-5-yl, 2H-1,3-oxazin-6-yl, 2H-1.3-
thiazin-2-yl, 2H-1,3-thiazin-4-yl, 2H-1,3-thiazin-5-yl, 2H-1,3-thiazin-6-yl, 4H-1.3-
oxazin-2-yl, 4H-1,3-oxazin-4-yl, 4H-1,3-oxazin-5-yl, 4H-1,3-oxazin-6-yl, 4H-1.3-
thiazin-2-yl, 4H-1,3-thiazin~4-yl, 4H-1,3-thiazin-5-yl, 4H-1,3-thiazin-6-yl, 6H-1.3-
oxazin-2-yl, 6H-1,3-oxazin-4-yl, 6H-1,3-oxazin-5-yl, 6H-1,3-oxazin-6-yl, 6H-1.3-
thiazin-2-yl, 6H-1,3-oxazin-4-yl, 6H-1,3-oxazin-5-yl, 6H-1,3-thiazin-6-yl, 2H-1.4-
oxazin-2-yl, 2H-1,4-oxazin-3-yl, 2H-1,4-oxazin-5-yl, 2H-1,4-oxazin-6-yl, 2H-1.4-
thiazin-2-yl, 2H-1,4-thiazin-3-yl, 2H-1,4-thiazin-5-yl, 2H-1,4-thiazin-6-yl, 4H-1.4-
oxazin-2-yl, 4H-1,4-oxazin-3-yl, 4H-1,4-thiazin-2-yl, 4H-1,4-thiazin-3-yl, 1,4-
dihydropyridazin-3-yl, 1,4-dihydropyridazin-4-yl, 1,4-dihydropyridazin-5-yl, 1,4-
dihydropyridazin-6-yl, 1,4-dihydropyrazin-2-yl, 1,2-dihydropyrazin-2-yl, 1,2-
dihydropyrazin-3-yl, 1,2-dihydropyrazin-5-yl, 1,2-dihydropyrazin-6-yl, 1,4-
dihydropyrimidin-2-yi, 1,4-dihydropyrimidin-4-yl, 1,4-dihydropyrimidin-5-yl, 1,4-
dihydropyrimidin-6-yl, 3,4-dihydropyrimidin-2-yl, 3,4-dihydropyrimidin-4-yl, 3,4-
dihydropyrimidin-5-yl or 3,4-dihydropyrimidin-6-yl;
for example 1,2,3,4-tetrahydropyridin-1-yl, 1,2,5,6-tetrahydropyridin-1-yl, 1,4-
dihydropyridin-1-yl, 1,2-dihydropyridin-1-yl, 2H-5,6-dihydro-1,2-oxazin-2-yl, 2H-5.6-
dihydro-1,2-thiazin-2-yl, 2H-3,6-dihydro-1,2-oxazin-2-yl, 2H-3,6-dihydro-1,2-thiazin-
2-yl, 2H-3,4-dihydro-1,2-oxazin-2-yl, 2H-3,4-dihydro-1,2-thiazin-2-yil 2,3,4,5-
tetrahydropyridazin-2-yl, 1,2,5,6-tetrahydropyridazin-1-yl, 1,2,5,6-
tetrahydropyridazin-2-yl, 1,2,3,6-tetrahydropyridazin-1-yl, 3,4,5,6-
tetrahydropyrimidin-3-yl, 1,2,3,4-tetrahydropyrazin-1 -yl, 1,2,3,4-tetrahydropyrimidin-
1-yl, 1,2,3,4-tetrahydropyrimidin-3-yl, 2,3-dihydro-1,4-thiazin-4-yl, 2H-1,2-oxazin-2-
yl, 2H-1,2-thiazin-2-yl, 4H-1,4-oxazin-4-yl, 4H-1,4-thiazin-4-yl, 1,4-dihydropyridazin-
1-yl, 1,4-dihydropyrazin-1-yl, 1,2-dihydropyrazin-1-yl, 1,4-dihydropyrimidin-1-yI or
3,4-dihydropyrimidin-3-yl;
for example pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl,
pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl, 1,3,5-triazin-2-yl, 1,2,4-
triazin-3-yl, 1,2,4-triazin-5-yl, 1,2,4-triazin-6-yl, 1,2,4,5-tetrazin-3-yl;
- C3-C6-alkenyl: for example 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-
butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl,
2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-
butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-
butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-
butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl,
1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl,
5-hexenyl, 1-methyi-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-
methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl,
4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-
pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-
4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl,
1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-
dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-
butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-
dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-
ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-
trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl- 1-propenyl and
1 -ethyl-2-methyl-2-propenyl;
- C2-C6-alkenyl: C3-C6-alkenyl as specified above and also ethenyl,
C3-C6-alkynyl: for example 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl,
1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-
butynyl, 1-methyl-3-butynyl, 2-methyI-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-
propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl,
1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-
pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-
1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl,
1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-
butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl;
- C2-C6-alkynyl: C3-C6-alkynyl as specified above and also ethynyl;
- C1-C4-haloalkyl: a C1-C4-alkyl radical as specified above which is partly or fully
substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example,
chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl,
trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-
fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-
trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-
fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-
difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3-chloropropyl, 2,3-dichloropropyl,
2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, 2,2,3,3,3-
pentafluoropropyl, heptafluoropropyl, 1-(fluoromethyl)-2-fluoroethyl, 1-
(chloromethyl)-2-chloroethyl, 1-(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-
chlorobutyl, 4-bromobutyl and nonafluorobutyl;
- C1-C6-haloalkyl: C1-C4-haloalkyl as specified above, and also, for example, 5-
fluoropentyl, 5-chloropentyl, 5-bromopentyl, 5-iodopentyl, undecafluoropentyl, 6-
fluorohexyl, 6-chlorohexyl, 6-bromohexyl, 6-iodohexyl and dodecafluorohexyl;
- C2-C6-haloalkenyl and also the haloalkenyl moieties of C2-C6-haloalkenyloxy: a
C2-C6-alkenyl radical as specified above which is partly or fully substituted by
fluorine, chlorine, bromine and/or iodine, for example 2-chlorovinyl, 2-chloroallyl, 3-
chloroallyl, 2,3-dichloroallyl, 3,3-dichloroallyl, 2,3,3-trichloroallyl, 2,3-dichlorobut-2-
enyl, 2-bromovinyl, 2-bromoallyl, 3-bromoallyl, 2,3-dibromoallyl, 3,3-dibromoallyl,
2,3,3-tribromoallyl or 2,3-dibromobut-2-enyl;
- C3-C6-haloalkynyl and the haloalkynyl moieties of C3-C6-haloalkynyloxy: a C3-C6-
alkynyl radical as specified above which is partly or fully substituted by fluorine,
chlorine, bromine and/or iodine, for example 1,1-difluoroprop-2-yn-1-yl, 3-iodoprop-
2-yn-1-yl, 4-fluorobut-2-yn-1-yl, 4-chlorobut-2-yn-1-yl, 1,1-difluorobut-2-yn-1-yl, 4-
iodobut-3-yn-1-yl, 5-fluoropent-3-yn-1-yl, 5-iodopent-4-yn-1-yl, 6-fluorohex-4-yn-1-
yl or 6-iodohex-5-yn-1-yl;
- C1-C4-cyanoalkyl: for example cyanomethyl, 1-cyanoeth-1-yl, 2-cyanoeth-1-yl, 1-
cyanoprop-1-yl, 2-cyanoprop-1-yl, 3-cyanoprop-1-yl, 1-cyanoprop-2-yl, 2-
cyanoprop-2-yl, 1-cyanobut-1-yl, 2-cyanobut-1-yl, 3-cyanobut-1-yl, 4-cyanobut-1-yl,
1-cyanobut-2-yl, 2-cyanobut-2-yl, 1-cyanobut-3-yl, 2-cyanobut-3-yl, 1-cyano-2-
methylprop-3-yl, 2-cyano-2-methylprop-3-yl, 3-cyano-2-methylprop-3-yl and 2-
cyanomethylprop-2-yl;
- C1-C6-cyanoalkyl and the cyanoalkyl moieties of C1-C6-cyanoalkoxy: C1-C4-cyano-
alkyl as specified above and also 5-cyanopentyl, 6-cyanohexyl;
- C1-C4-alkoxy, for example methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-
methylpropoxy, 2-methylpropoxy and 1,1-dimethylethoxy;
- C1-C6-alkoxy: C1-C4-alkoxy as specified above, and also, for example, pentoxy, 1-
methylbutoxy, 2-methylbutoxy, 3-methoxylbutoxy, 1,1-dimethylpropoxy, 1,2-di-
methylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-
methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy,1,2-di-
methylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-
dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-tri-
methylpropoxy, 1-ethyl-1-methylpropoxy and 1 -ethyl-2-methylpropoxy;
- C2-C6-alkenyloxy: for example ethen-1-yloxy, ethen-2-yloxy, prop-1-en-1-yloxy,
prop-2-en-1-yloxy, 1-methylethenyloxy, buten-1-yloxy, buten-2-yloxy, buten-3-
yloxy, 1-methylprop-1-en-1-yloxy, 2-methylprop-1-en-1-yloxy, 1-methylprop-2-en-1-
yloxy, 2-methylprop-2-en-1-yloxy, penten-1-yloxy, penten-2-yloxy, penten-3-yloxy,
penten-4-yloxy, 1-methylbut-1-en-1-yloxy, 2-methylbut-1-en-1-yloxy, 3-methylbut-1-
en-1-yloxy, 1-methylbut-2-en-1-yloxy, 2-methylbut-2-en-1-yloxy, 3-methylbut-2-en-
1-yloxy, 1-methylbut-3-en-1-yloxy, 2-methylbut-3-en-1-yloxy, 3-methylbut-3-en-1-
yloxy, 1,1-dimethylprop-2-en-1-yloxy, 1,2-dimethylprop-1-en-1-yloxy, 1,2-dimethyl-
prop-2-en-1-yloxy, 1-ethylprop-1-en-2-yloxy, 1-ethylprop-2-en-1-yloxy, hex-1-en-1-
yloxy, hex-2-en-1-yloxy, hex-3-en-1-yloxy, hex-4-en-1-yloxy, hex-5-en-1-yloxy, 1-
methylpent-1-en-1-yloxy, 2-methylpent-1-en-1-yloxy, 3-methylpent-1-en-1-yloxy, 4-
methyipent-1-en-1-yloxy, 1-methylpent-2-en-1-yloxy, 2-methylpent-2-en-1-yloxy, 3-
methylpent-2-en-1-yloxy, 4-methylpent-2-en-1-yloxy, 1-methylpent-3-en-1-yloxy, 2-
methylpent-3-en-1-yloxy, 3-methylpent-3-en-1-yloxy, 4-methylpent-3-en-1-yloxy, 1-
methylpent-4-en-1-yloxy, 2-methylpent-4-en-1-yloxy, 3-methylpent-4-en-1-yloxy, 4-
methylpent-4-en-1-yloxy, 1,1-dimethylbut-2-en-1-yloxy, 1,1-dimethylbut-3-en-1-
yloxy, 1,2-dimethylbut-1-en-1-yloxy, 1,2-dimethylbut-2-en-1-yloxy, 1,2-dimethylbut-
3-en-1-yloxy, 1,3-dimethylbut-1-en-1-yloxy, 1,3-dimethylbut-2-en-1-yloxy, 1,3-
dimethylbut-3-en-1-yloxy, 2,2-dimethylbut-3-en-1-yloxy, 2,3-dimethylbut-1-en-1-
yloxy, 2,3-dimethylbut-2-en-1-yloxy, 2,3-dimethylbut-3-en-1-yloxy, 3,3-dimethylbut-
1-en-1-yloxy, 3,3-dimethylbut-2-en-1-yloxy, 1-ethylbut-1-en-1-yloxy, 1-ethylbut-2-
en-1-yloxy, 1-ethylbut-3-en-1-yloxy, 2-ethylbut-1-en-1-yloxy, 2-ethylbut-2-en-1-
yloxy, 2-ethylbut-3-en-1-yloxy, 1,1,2-trimethylprop-2-en-1-yloxy, 1-ethyl-1-
methylprop-2-en-1-yloxy, 1-ethyl-2-methylprop-1-en-1-yloxy and 1 -ethyls-
methyl pro p-2-en-1 -yloxy;
- C3-C6-alkynyloxy: for example prop-1-yn-1 -yloxy, prop-2-yn-1-yloxy, but-1-yn-1-
yloxy, but-1-yn-3-yloxy, but-1-yn-4-yloxy, but-2-yn-1-yloxy, pent-1-yn-1-yloxy, pent-
1-yn-3-yloxy, pent-1-yn-4-yloxy, pent-1-yn-5-yloxy, pent-2-yn-1-yloxy, pent-2-yn-4-
yloxy, pent-2-yn-5-yloxy, 3-methylbut-1-yn-3-yloxy, 3-methylbut-1-yn-4-yloxy, hex-
1-yn-1-yloxy, hex-1-yn-3-yloxy, hex-1-yn-4-yloxy, hex-1-yn-5-yloxy, hex-1-yn-6-
yloxy, hex-2-yn-1-yloxy, hex-2-yn-4-yloxy, hex-2-yn-5-yloxy, hex-2-yn-6-yloxy, hex-
3-yn-1-yloxy, hex-3-yn-2-yloxy, 3-methylpent-1-yn-1-yloxy, 3-methylpent-1-yn-3-
yloxy, 3-methylpent-1-yn-4-yloxy, 3-methylpent-1-yn-5-yloxy, 4-methylpent-1-yn-1-
yloxy, 4-methylpent-2-yn-4-yloxy and 4-methylpent-2-yn-5-yloxy;
- C1-C4haloalkoxy: a C1-C4alkoxy radical as specified above which is partly or fully
substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example,
fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorodifluoromethoxy,
bromodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromomethoxy, 2-
iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-
chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy,
pentafluoroethoxy, 2-fluoropropoxy, 3-fluoropropoxy, 2-chloropropoxy, 3-
chloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 2,2-difluoropropoxy, 2,3-
difluoropropoxy, 2,3-dichloropropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy,
2,2,3,3,3-pentafluoropropoxy, heptafluoropropoxy, 1 -(fluoromethyl)-2-fluoroethoxy,
1 -(chloromethyl)-2-chloroethoxy, 1 -(bromomethyl)-2-bromoethoxy, 4-fluorobutoxy,
4-chlorobutoxy, 4-bromobutoxy and nonafluorobutoxy;
- C1-C6-haloalkoxy: C1-C4-haloalkoxy as specified above, and also, for example, 5-
fluoropentoxy, 5-chloropentoxy, 5-bromopentoxy, 5-iodopentoxy,
undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-
iodohexoxy and dodecafluorohexoxy;
- C1-C6-alkoxy-C2-C4-alkoxy: C2-C4-alkoxy substituted by C1-C4-alkoxy as specified
above, i.e., for example, 2-(methoxy)ethoxy, 2-(ethoxy)ethoxy, 2-(propoxy)ethoxy,
2-(1-methylethoxy)ethoxy, 2-(butoxy)ethoxy, 2-(1-methylpropoxy)ethoxy, 2-(2-
methylpropoxy)ethoxy, 2-(1,1-dimethylethoxy)ethoxy, 2-(methoxy)propoxy, 2-
(ethoxy)propoxy, 2-(propoxy)propoxy, 2-(1-methylethoxy)propoxy, 2-(butoxy)-
propoxy, 2-(1-methylpropoxy)propoxy, 2-(2-methylpropoxy)propoxy, 2-(1,1-
dimethylethoxy)propoxy, 3-(methoxy)propoxy, 3-(ethoxy)propoxy, 3-(propoxy)-
propoxy, 3-(1-methylethoxy)propoxy, 3-(butoxy)propoxy, 3-(1-methylpropoxy)-
propoxy, 3-(2-methylpropoxy)propoxy, 3-(1,1-dimethylethoxy)propoxy, 2-
(methoxy)butoxy, 2-(ethoxy)butoxy, 2-(propoxy)butoxy, 2-(1-methylethoxy)butoxy,
2-(butoxy)butoxy, 2-(1-methylpropoxy)butoxy, 2-(2-methylpropoxy)butoxy, 2-(1,1-
dimethylethoxy)butoxy, 3-(methoxy)butoxy, 3-(ethoxy)butoxy, 3-(propoxy)butoxy, 3-
(l-methylethoxy)butoxy, 3-(butoxy)butoxy, 3-(1-methylpropoxy)butoxy, 3-(2-
methylpropoxy)butoxy, 3-(1,1-dimethylethoxy)butoxy, 4-(methoxy)butoxy, 4-
(ethoxy)butoxy, 4-(propoxy)butoxy, 4-(1-methylethoxy)butoxy, 4-(butoxy)butoxy, 4-
(l-methylpropoxy)butoxy, 4-(2-methylpropoxy)butoxy and 4-(1,1-dimethyl-
ethoxy)butoxy;
- C1-C4-alkoxycarbonyl: for example, methoxycarbonyl, ethoxycarbonyl,
propoxycarbonyl, 1-methylethoxycarbonyl, butoxycarbonyl, 1-methylpropoxy-
carbonyl, 2-methylpropoxycarbonyl or 1,1-dimethylethoxycarbonyl;
- C1-C4-alkylthio: for example methylthio, ethylthio, propylthio, 1-methylethylthio,
butylthio, 1-methylpropylthio, 2-methylpropylthio and 1,1-dimethylethylthio;
- C1-C6-alkylthio: C1-C4-alkylthio as specified above, and also, for example,
pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2-
dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1,2-
dimethylpropylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-
methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio,
2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio,
2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2-trimethylpropylthio, 1-ethyl-1-
methylpropylthio and 1-ethyl-2-methylpropylthio;
- C1-C4alkylsulfinyl (C1-C4-alkyl-S(=0)-): for example methylsulfinyl, ethylsulfinyl,
propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2-methyl-
propylsulfinyl, 1,1-dimethylethylsulfinyl;
- C1-C4-alkylsulfonyl (C1-C4-alkyl-S(=O)2-): for example rnethylsulfonyl, ethylsulfonyl,
propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-
methylpropylsulfonyl, 1,1-dimethylethylsulfonyl;
- C1-C4-alkylamino: for example methylamino, ethylamino, propylamine 1-methyl-
ethylamino, butylamino, 1-methylpropylamino, 2-methylpropylamino, 1,1-dimethyl-
ethylamino;
- di-(C1-C4-alkyl)amino: for example N,N-dimethylamino, N,N-diethylamino, N,N-
dipropylamino, N,N-di-(1-methylethyl)amino, N,N-dibutylamino, N,N-di-(1-methyl-
propyl)amino, N,N-di-(2-methylpropyl)amino, N,N-di-(1,1-dimethylethyl)amino, N-
ethyl-N-methylamino, N-methyl-N-propylamino, N-methyl-N-(1 -methylethyl)amino,
N-butyl-N-methylamino, N-methyl-N-(1-methylpropyl)amino, N-methyl-N-(2-
methylpropyl)amino, N-(1,1-dimethylethyl)-N-methylamino, N-ethyl-N-propylamino,
N-ethyl-N-(1 -methylethyl)amino, N-butyl-N-ethylamino, N-ethyl-N-(1 -
methylpropyl)amino, N-ethyl-N-(2-methylpropyl)amino, N-ethyl-N-(1,1-dimethyl-
ethyl)amino, N-(1-methylethyl)-N-propylamino, N-butyl-N-propylamino, N-(1-
methylpropyl)-N-propylamino, N-(2-methylpropyl)-N-propylamino, N-(1,1-dimethyl-
ethyl)-N-propylamino, N-butyl-N-(1 -methylethyl)amino, N-(1 -methylethyl)-N-(1 -
methylpropyl)amino, N-(1-methylethyl)-N-(2-methylpropyl)amino, N-(1,1-dimethyl-
ethyl)-N-(1-methylethyl)amino, N-butyl-N-(1-methylpropyl)amino, N-butyl-N-(2-
methylpropyl)amino, N-butyl-N-(1,1 -dimethylethyl)amino, N-(1 -methylpropyl)-N-(2-
methylpropyl)amino, N-(1,1-dimethylethyl)-N-(1-methylpropyl)amino and N-(1,1-
dimethylethyl)-N-(2-methylpropyl)amino;
- (C1-C4-alkylamino)carbonyl: for example methylaminocarbonyl, ethylamino-
carbonyl, propylaminocarbonyl, 1-methylethylaminocarbonyl, butylaminocarbonyl,
1-methylpropylaminocarbonyl, 2-methylpropylaminocarbonyl or 1,1-dimethylethyl-
aminocarbonyl;
- di-(C1-C4)-alkylaminocarbonyl: for example N,N-dimethylaminocarbonyl, N,N-
diethylaminocarbonyl, N,N-di-(1-methylethyl)aminocarbonyl, N,N-dipropylamino-
carbonyl, N,N-dibutylaminocarbonyl, N,N-di-(1-methylpropyl)aminocarbonyl, N,N-
di-(2-methylpropyl)aminocarbonyl, N,N-di-(1,1-dimethylethyl)aminocarbonyl, N-
ethyl-N-methylaminocarbonyl, N-methyl-N-propylaminocarbonyl, N-methyl-N-(1 -
methylethyl)aminocarbonyl, N-butyl-N-methylaminocarbonyl, N-methyl-N-(1 -
methylpropyl)aminocarbonyl, N-methyl-N-(2-methylpropyl)aminocarbonyl, N-(1,1-
dimethylethyl)-N-methylaminocarbonyl, N-ethyl-N-propylaminocarbonyl, N-ethyl-N-
(1 -methylethyl)aminocarbonyl, N-butyl-N-ethylaminocarbonyl, N-ethyl-N-(1 -methyl-
propyl)aminocarbonyl, N-ethyl-N-(2-methylpropyl)aminocarbonyl, N-ethyl-N-(1,1-
dimethylethyl)aminocarbonyl, N-(1 -methylethyl)-N-propylaminocarbonyl, N-butyl-N-
propylaminocarbonyl, N-(1-methylpropyl)-N-propylaminocarbonyl, N-(2-methyl-
propyl)-N-propylaminocarbonyl, N-(1,1-dimethylethyl)-N-propylaminocarbonyl, N-
butyl-N-(1 -methylethyl)aminocarbonyl, N-(1 -methylethyl)-N-(1 -methylpropyl)amino-
carbonyl, N-(1-methylethyl)-N-(2-methylpropyl)aminocarbonyl, N-(1,1-dimethyl-
ethyl)-N-(1-methylethyl)aminocarbonyl, N-butyl-N-(1-methylpropyl)aminocarbonyl,
N-butyl-N-(2-methylpropyl)aminocarbonyl, N-butyl-N-(1,1-dimethylethyl)amino-
carbonyl, N-(1-methylpropyl)-N-(2-methylpropyl)aminocarbonyl, N-(1,1-
dimethylethyl)-N-(1 -methylpropyl)aminocarbonyl or N-(1,1 -dimethylethyl)-N-(2-
methylpropyl)aminocarbonyl.
All phenyl rings are preferably unsubstituted or carry from one to three halogen atoms
and/or one nitro group, one cyano radical and/or one or two methyl, trifluoromethyl,
methoxy or trifluoromethoxy substituents.
'In a particularly preferred embodiment of the process according to the invention, the
variables R1, R2 and R3, each alone or in combination, are defined as follows:
R1 hydrogen, C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-
alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-
alkyl,
very preferably hydrogen or C1-C4-alkyl,
more preferably hydrogen, methyl or ethyl,
especially preferably methyl;
likewise preferably hydrogen, amino or C1-C4-alkyl,
more preferably hydrogen, amino, methyl or ethyl,
especially preferably amino or methyl;
likewise preferably hydrogen, amino or C1-C4-alkyl,
more preferably hydrogen or amino,
especially preferably hydrogen;
R2 hydrogen, C1-C4-alkyl or C1-C4-haloalkyl,
more preferably hydrogen, methyl, difluoromethyl or trifluoromethyl,
especially preferably trifluoromethyl;
R3 hydrogen or C1-C4-alkyl,
more preferably hydrogen.
In a further preferred embodiment of the process according to the invention, X1, X2 and
X3 are each oxygen.
The Ar group specified is preferably a group of the general formula Ar-1 ^

where
* represents the bond of Ar to the C(X3) group;
where X is preferably oxygen;
** represents the bond of Ar to the directly adjacent nitrogen atom; and
Ra, Rb, Rc and Rd are each independently
hydrogen, halogen, cyano or C1-C4-haloalkyl.
' In a particularly preferred embodiment of the process according to the invention, the
variables Ra, Rb, Rc and Rd, each alone or in combination, are defined as follows:
Ra hydrogen, halogen or cyano,
especially preferably hydrogen, fluorine, chlorine or cyano,
very preferably hydrogen, chlorine or cyano,
exceptionally preferably hydrogen or chlorine;
Rb hydrogen:
Rc hydrogen or halogen,
especially preferably hydrogen, fluorine or chlorine,
very preferably hydrogen or fluorine,
exceptionally preferably fluorine;
Rd hydrogen.
The specified A radical derived from a primary or secondary amine is generally a group
of the formula -NR4R5 where the variables R4 and R5 are each independently defined
as follows:
R4, R5 hydrogen, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl,
where the last three radicals mentioned may be substituted by a radical
selected from the group of CN, NO2, C1-C4-alkoxy, C1-C4-alkylthio, formyl,
C1-C4-alkylcarbonyl, C1-C4-alkoxycarbonyl, (C1-C4-alkylamino)carbonyl,
(C1-C4-dialkylamino)carbonyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl,
C3-C8-cycloalkyl, 3- to 6-membered heterocyclyl having from one to four
heteroatoms selected from oxygen, sulfur, nitrogen and an NR6 group,
where R6 is hydrogen, C1-C6-alkyl, C3-C6-alkenyl or C3-C6-alkynyl;
or
phenyl which may itself be partly or fully halogenated and/or may carry
from one to three substituents selected from the group of cyano,
nitro, C1-C4-alkyl, C1-C4-fluoroalkyl, C1-C4-alkoxy, (C1-C4-
alkyl)amino, (C1-C4-dialkyl)amino, trifluoromethylsulfonyl, formyl or
C1-C6alkyloxycarbonyl;
C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-haloalkynyl;
C3-C8-cycloalkyl, C3-C8-cycloalkenyl, 3- to 6-membered heterocyclyl having
from one to four heteroatoms selected from oxygen, sulfur, nitrogen and an
NR6 group,
where R6 is hydrogen, C1-C6-alkyl, C3-C6-alkenyl or C3-C6-alkynyl;
phenyl or naphthyl;
where the last five radicals mentioned, C3-C8-cycloalkyl, C3-C8-
cycloalkenyl, 3- to 6-membered heterocyclyl, phenyl and naphthyl, may
themselves be partly or fully halogenated and/or may carry from one to
three substituents selected from the group of cyano, nitro, C1-C4-alkyl,
C1-C4-fluoroalkyl, C1-C4-alkoxy, (C1-C4-alkyl)amino, (d-C1-C4ialkyl)amino,
trifluoromethylsulfonyl, formyl, C1-C4-alkyloxycarbonyl or phenoxy; or
R4 and R5 together form a saturated or partly unsaturated 5- to 6-membered nitrogen
heterocycle which may have one or two carbonyl groups, thiocarbonyl groups
and/or one or two further heteroatoms selected from 0, S, N and an NR6
group as ring members,
where R6 is hydrogen, C1-C6-alkyl, C3-C6-alkenyl or C3-C6-alkynyl,
and which may itself be substituted by C1-C4-alkyl, C1-C4-alkoxy and/or
C1-C4-haloalkyl.
For the process according to the invention, it has been found to be particularly
advantageous when A is a group of the formula -NR4R5 where the substituents R4 and
R5 are each independently
hydrogen or C1-C4-alkyl which may itself be substituted by a substituent selected
from the group of
halogen, cyano, C3-Ce-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-
alkoxycarbonyl, phenyl which may itself carry from one to three radicals
from the group of halogen or C1-C4-alkoxy;
furyl, thienyl and 1,3-dioxolanyl;
preferably halogen, cyano and C1-C4-alkoxy;
very preferably halogen.
In a preferred embodiment of the invention, A is a group of the formula -NR4R5 where
the substituents R4 and R5 are each independently hydrogen or C1-C4-alkyl.
In a particularly preferred embodiment of the invention, A is a group of the formula
-NR4R5 where
R4 is hydrogen, C1-C6-alkyl, C1-C4-haloalkyl, C2-C6-alkenyl or C2-C6-alkynyl,
especially preferably hydrogen or C1-C6-alkyl,
very preferably C1-C4-alkyl,
more preferably methyl; and
R5 is C1-C6-alkyl, C1-C4-haloalkyl, C3-C8-cycloalkyl or phenyl,
especially preferably C1-C4-alkyl,
very preferably C1-C4-alky!.
"The inventive process steps may be performed either batchwise or continuously in
reaction vessels suitable therefor.
In the batchwise procedure, stirred tanks and stirred reactors will typically be used.
These are generally equipped with suitable heat exchangers or a cooling jacket to
remove the heat of reaction.
The inventive reaction steps are performed continuously likewise in the reactors
suitable therefor, for example in stirred tanks, stirred tank batteries and tubular
reactors, of which preference is given to reactors having low backmixing.
The amount of solvent or diluent is generally selected such that the reaction mixtures
remain free-flowing during the reaction.
The 3-phenyl(thio)uracils and -dithiouracils of the formula I are prepared by reacting a
carbamate of the formula II with an enamine of the formula III:
The variables X1, X2, X3, R1, R2, R3 and also Ar and A are each as defined above, and
are especially preferably as defined with preference in the description.
L1 is a nucleophilically displaceable leaving group,
preferably C1-C6-alkoxy or C1-C6-alkylthio,
more preferably C1-C6-alkoxy.
L2 is a nucleophilically displaceable leaving group;
preferably C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy>
C1-C4-alkylthio-C2C4-alkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C3-C6-
alkynyloxy, C3-C6-haloalkynyloxy, C3-C8-cycloalkyloxy, C1-C6-cyanoalkoxy or
benzyloxy,
which may itself be partly or fully halogenated on the phenyl ring and/or
may be substituted by from one to three radicals from the group of cyano,
nitro, C1-C4-alkyl, C1-C4-alkoxy and C1-C4-alkylthio;
preferably C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4alkoxy-C1-C4alkoxy, C2-C6-
alkenyloxy, C2-C6-haloalkenyloxy, C3-C6-alkynyloxy or C3-C6-haloalkynyloxy;
very preferably C1-C6-alkoxy, C1-C4-alkoxy-C2-C4-alkoxy, C2-C6-alkenyloxy or
C3-C6-alkynyloxy;
exceptionally preferably C1-C6-alkoxy.
This reaction of the carbamates of the formula II with enamines of the formula III is
effected typically at temperatures above room temperature, for example from 25°C to
200°C, preferably from90°C to 190.°C, more preferably from100°C to 140°C in an inert
organic solvent in the presence of a base (cf., for example, WO 99/31091).
The reaction pressure is of minor importance for the success of the process according
to the invention and may, for example, be in the range from 500 mbar to 10 bar.
Preference is given to carrying out the reaction in the region of standard pressure, i.e.
in the range from 0.9 to 1.2 bar.
The reaction time required for the reaction is generally in the range from 1 h to 24 h,
and in particular in the range from 2 h to 8 h.
The reaction may in principle be carried out in substance. However, preference is given
to reacting the carbamates of the formula II with the enamines of the formula III in an
organic solvent. Suitable in principle are all solvents which are capable of dissolving
the carbamates of the formula II and the enamines of the formula III at least partly and
preferably fully under reaction conditions. Preferred solvents are polar protic solvents.
Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane
and mixture of C5-C8-alkanes, aromatic hydrocarbons such as toluene, o-, m- and p-
xylene, halogenated hydrocarbons such as methylene chloride, chloroform and
chlorobenzene, ethers such as diethyl ether, diisopropyl ether, tert-butyl methyl ether,
dioxane, diethylene glycol dimethyl ether, anisole and tetrahydrofuran, nitriles such as
acetonitrile and propionitrile, alcohols such as methanol, ethanol, n-propanol,
isopropanol, n-butanol and tert-butanol, carboxylic esters such as butyl acetate, and
also dimethyl sulfoxide, dimethylformamide, dimethylacetamide and N-
methylpyrrolidone; more preferably dimethylformamide, dimethylacetamide and N-
methylpyrrolidone.
It is also possible to use mixtures of the solvents mentioned.
Useful bases are generally inorganic compounds such as alkali metal and alkaline
earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium
hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as
lithium oxide, sodium oxide, calcium oxide and magnesium oxide, alkali metal and
alkaline earth metal hydrides such as lithium hydride, sodium hydride, potassium
hydride and calcium hydride, alkali metal amides such as lithium amide, sodium amide
and potassium amide, alkali metal and alkaline earth metal carbonates such as lithium
carbonate, sodium carbonate, potassium carbonate, calcium carbonate and cesium
carbonate, and also alkali metal hydrogencarbonates such as sodium
"hydrogencarbonate, organometallic compounds, especially alkali metal alkyls such as
methyllithium, butyllithium and phenyllithium, alkali metal and alkaline earth metal
alkoxides such as lithium methoxide, sodium methoxide, sodium ethoxide, potassium
ethoxide, potassium tert-butoxide, potassium tert-pentoxide and dimethoxymagnesium,
and also organic bases, for example tertiary amines such as trimethylamine,
triethylamine, diisopropylethylamine and N-methylpiperidine, pyridine, substituted
pyridines such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic
amines. Particular preference is given to alkali metal and alkaline earth metal
hydroxides, alkali metal and alkaline earth metal carbonates and also alkali metal and
alkaline earth metal alkoxides.
The bases are generally used in excess, more preferably with from 1.1 to 3 equivalents
based on the carbamate of the formula II, and they may also be used as the solvent. It
may be advantageous to add the base offset over a period of time.
The bases are used preferably at from 1.1 to 2.4 equivalents, very preferably at from
2.2 to 2.4 equivalents, more preferably at 2.3 equivalents, based on the carbamate II.
The reactants are generally reacted with one another in equimolar amounts. It may be
advantageous to use one component in an excess based on the other components.
Preference is given to using the compounds in a molar ll:lll ratio in the range from 1.5:1
to 1:1.5, more preferably from 1:1 to 1:1.2, especially preferably from 1:1.
Preference is given to partly removing the compounds L1-H and L2-H formed in the
course of the reaction of the carbamates of the formula II with the enamines of the
formula III during the reaction, especially when the compounds L1-H and L2"H are a
C1-C4-alkanol such as methanol or ethanol. To this end, the reaction will be carried out
in a manner known per se at a temperature and a pressure at which the compounds
L1-H and L2-H, if appropriate, are distilled out of the reaction mixture as an azeotrope
with the solvent. If appropriate, fresh solvent can be introduced into the mixture for
compensation or the solvent distilled off with the compounds L1-H and L2-H can be
recycled into the reaction after optional distillative depletion of the compounds L1-H and
L2-H.
For these reasons, it is advantageous when the solvent used has a boiling point of at
least 10°C, in particular at least 30°C, above the boiling point of the compounds L1-H
and L2"H formed in the reaction (each at atmospheric pressure).
Appropriately, the reaction of the carbamates of the formula II with the enamines of the
formula III is carried out in an apparatus which is equipped with at least one distillation
or rectification apparatus, for example a distillation column, which firstly allows the
compounds L1-H and L2-H, if appropriate together with the solvent, to be distilled off
and simultaneously enables removal and recycling of any solvent distilled off with the
compounds L1-H and L2-H.
For the reaction, the compounds II and III may be contacted with one another in any
desired manner, i.e. the reactants and the base may be introduced into the reaction
vessel separately, simultaneously or successivejy_and reacted. For example, the
compounds II and III may be initially charged in a reaction vessel, if appropriate with
the desired solvent, and then the desired reaction conditions may be attained.
However, it is also possible to introduce the majority or entirety of compounds II and III,
if appropriate in a solvent under reaction conditions, into the reaction vessel.
In a preferred embodiment of the invention, the majority, in particular at least 80% and
more preferably the entirety or virtually the entirety (> 95%) of the carbamates of the
formula II are initially charged, and the majority, in particular at least 80% and more
preferably the entirety or virtually the entirety (> 95%) of the enamine of the formula III
is added thereto under reaction conditions in the course of the reaction, for example
over a period of from 0.5 to 20 h and in particular from 1 to 10 h. To this end, the
enamines of the formula III will preferably be dissolved in a solvent.
In a further preferred embodiment of the invention, the compounds II and III are initially
charged and then the majority, in particular at least 80% and more preferably the
entirety or virtually the entirety (> 95%), of the base is added thereto. The reaction may
if appropriate be completed by metering in further base.
The 3-phenyl(thio)uracils and -dithiouracils of the formula I can be isolated from the
reaction mixture in a manner known per se.
When the reaction has been carried out in a solvent, the reaction mixture will generally
be concentrated and/or cooled and/or a precipitant will be added. Suitable precipitants
are solvents in which the 3-phenyl(thio)uracils and -dithiouracils of the formula I
dissolve only to a slight extent, if at all, at least at temperatures below 25°C. These
include in particular aliphatic and cycloaliphatic hydrocarbons such as pentane,
hexane, cyclohexane, heptane, petroleum ether, toluene and the like. The precipitation
or crystallization may be followed by further purification measures. When the reaction is
carried out as preferred in an alcohol, in particular in methanol or ethanol, or in an
alkylbenzene, it is generally unnecessary to add a precipitant.
For the workup, it is also advantageous to adjust the pH of the reaction mixture to
pH sulfuric acid. In particular, it is advantageous when the pH of the reaction mixture is at the end.
The enamines of the formula III required for the preparation of the 3-phenyl(thio)uracils
and -dithiouracils of the formula I are disclosed in the literature (for example A. Lutz, A.
and S. Trotto, J. of Heterocyclic Chem. 1972, 9, 3, 513-522) and can be prepared in
accordance with the cited literature.
In particular, it is possible by this route to prepare 3-phenyluracils of the formula I.A.1
L1 is a nucleophiiically displaceable leaving group,
preferably C1-C6-alkoxy or C1-C6alkylthio,
more preferably C1-C6-alkoxy,
especially preferably C1-C4-alkoxy,
very preferably methoxy or ethoxy;
L2 is a nucleophiiically displaceable leaving group;
preferably C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy,
C1-C4-alkylthio-C2C4-alkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy,
C3-C6-alkynyloxy, C3-C6-haloalkynyloxy, C3-C8-cycloalkyloxy,
C1-C6-cyanoalkoxy or benzyloxy,
which may itself be partially or fully halogenated on the phenyl ring and/or
be substituted by from one to three radicals from the group of cyano, nitro,
C1-C4-alkyl, C1-C4-alkoxy and C1-C4-alkylthio;
preferably C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy,
C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C3-C6-alkynyloxy or
C3-C6-haloalkynyloxy;
very preferably C1-C6-alkoxy, C1-C4-alkoxy-C2-C4-alkoxy, C2-C6-alkenyloxy or
C3-C6-alkynyloxy;
exceptionally preferably C1-C6-alkoxy.
Preference is given to the preparation especially of those 3-phenyluracils of the formula
I.A.1 where Rb and Rd = hydrogen, in which the variables R1, R2, R3, Ra, Rc, and also
R4 and R5, each alone or in combination with one another, are defined as follows:
R1 is hydrogen, C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl,
C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-
C1-C4-alkyl;
very preferably hydrogen or C1-C4-alky!,
more preferably hydrogen, methyl or ethyl,
especially preferably methyl;
likewise preferably hydrogen, amino or C1-C4-alkyl,
more preferably hydrogen, amino, methyl or ethyl,
especially preferably amino or methyl;
likewise preferably hydrogen, amino or C1-C4-alkyl,
more preferably hydrogen or amino,
especially preferably hydrogen;
R2 is hydrogen, C1-C4-alkyl or C1-C4-haloalkyl,
more preferably hydrogen, methyl, difluoromethyl or trifluoromethyl,
especially preferably trifluoromethyl;
R3 is hydrogen or C1-C4-alkyl,
more preferably hydrogen.
Ra is hydrogen, halogen or cyano,
especially preferably hydrogen, fluorine, chlorine or cyano,
very preferably hydrogen, chlorine or cyano,
exceptionally preferably hydrogen or chlorine,
very exceptionally preferably hydrogen;
Rc is hydrogen or halogen,
especially preferably hydrogen, fluorine or chlorine,
very preferably hydrogen or fluorine,
exceptionally preferably fluorine;
R4 and R5 are each independently
hydrogen or C1-C6-alkyl which may itself be substituted by a substitutent selected
from the group of
halogen, cyano and C1-C4-alkoxy, preferably halogen;
especially preferably
R4 is hydrogen, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl,
very preferably hydrogen or C1-C6-alkyl,
more preferably C1-C4-alkyl,
exceptionally preferably methyl; and
R5 is C1-C6-alkyl, C3-C8-cycloalkyl or phenyl,
very preferably C1-C6-alkyl,
more preferably C1-C4-alkyl.
In particular, 3-phenyl(thio)uracils and -dithiouracils of the formula I where
R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl,
C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl, phenyl-C1-C4-alkyl or amino;
can be prepared by reacting carbamates of the formula II

where the variables X1, X3, Ar and A are each as defined above and L1 is a
nucleophiiically displaceable leaving group
with enamines of the formula III

where R1 is hydrogen, the variables X2, R2 and R3 are each as defined above and L2 is
a nucleophiiically displaceable leaving group; and
then reacting the resulting 3-phenyl(thio)uracil and -dithiouracil of the formula I where
R1 is hydrogen
with an alkylating agent of the formula VI
R1-L4 VI
where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl,
C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or
phenyl-C1-C4-alkyl; and
L4 is a nucleophiiically displaceable leaving group;
to give 3-phenyl(thio) uracils and -dithiouracils of the formula I where R1 is
C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-
alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-d-
C4-alkyl;
or
with an aminating agent of the formula VII
H2N—L5 VII
where L5 is a nucleophiiically displaceable leaving group
to give 3-phenyl(thio)uracils and -dithiouracils of the formula I where R1 is NH2.
For the preparation of the 3-phenyl(thio)uracils and -dithiouracils of the formula I where
R1 is hydrogen, the aforementioned reaction conditions, especially the reaction
conditions mentioned above as preferred, apply.
L4 in the alkylating agent of the formula VI is a nucleophilically displaceable leaving
group,
preferably halogen, hydrogensulfate, C1-C6-alkylsulfate, sulfate, C1-C6-alkyl-
sulfonyloxy, C1-C6-haloalkylsulfonyloxy or phenylsulfonyloxy,
where the phenyl ring is optionally mono- or polysubstituted by halogen,
nitro, C1-C6-alkyl or C1-C6-haloalkyl,
more preferably halogen, hydrogensulfate, C1-C6-alkylsulfonyloxy, C1-C6-halo-
alkylsulfonyloxy, phenylsulfonyloxy, p-toluenesulfonyloxy, p-
chlorophenylsulfonyloxy, p-bromophenylsulfonyloxy or p-nitrophenylsulfonyloxy,
especially preferably chlorine, methylsulfonyloxy, trifluoromethylsulfonyloxy or
phenylsulfonyloxy.
L5 in the aminating agent of the formula VII is a nucleophilically displaceable leaving
group,
preferably halogen, hydrogensulfate, C1-C6-alkylsulfonyloxy, C1-C6-
haloalkylsulfonyloxy, phenylsulfonyloxy or phenyloxy,
where the phenyl ring is optionally mono- or polysubstituted by halogen,
nitro, C1-C6-alkyl or C1-C6-haloalkyl,
more preferably halogen, hydrogensulfate, C1-C6-alkylsulfonyloxy, C1-C6-halo-
alkylsulfonyloxy, phenylsulfonyloxy, p-toluenesulfonyloxy, p-chlorophenyl-
sulfonyloxy, p-bromophenylsulfonyloxy or p-nitrophenylsulfonyloxy,
especially preferably chlorine, methylsulfonyloxy, trifluoromethylsulfonyloxy or
phenylsulfonyloxy.
The process for alkylating or aminating the compound I where R1 = hydrogen is
surprising in that the formation of corresponding N-alkylsulfonamides or mixtures of N-
alkylsulfonamides or N-alkyl-substituted (thio)uracils or dithiouracils would have been
expected. It is known that sulfuric diamides are alkylated in a simple manner with
sulfuric diesters or arenesulfonic esters in the presence of a base; see, for example,
R. Sowada, J. Prakt. Chem. 25, 88 (1964). In the case of trisubstituted sulfuric
diamides, the formation of tetrasubstituted sulfuric diamides is known; see B. Unterhalt,
E. Seebach, Arch. Pharm. 314, 51 (1981). It is likewise possible to alkylate sulfuric
diamides in which the amide function already carrys an acyl radical; see K.C.C.
Bancroft et al., J. Heterocycl. Chem. 15, 1521 (1978); A. Martinex et al., Bioorg. Med.
Chem. Lett. 9 (21), 3133 (1999). The person skilled in the art would therefore have
expected, owing to the easy alkylatability of the sulfamide side chain, the preferred
alkylation on the sulfonamide nitrogen atom or at least the formation of dialkylated
' products.
The N-alkylation of the compound I on the free (thio)uracil nitrogen atom succeeds in a
manner known per se for uracils by reacting the compound I where R1 = hydrogen with
an alkylating agent R1-L4 (VI), as described, for example, in US 4,943,309, whose
disclosure on alkylation is hereby incorporated fully by reference.
Preferred alkylating agents are C1-C4-alkyl halides, di-C1-C4-alkyl sulfates, C1-C4-alkyl
phenylsulfonates where the phenyl radical is optionally mono- or disubstituted by
halogen, nitro or C1-C6-alkyl. Particularly preferred alkylating agents are methylating
agents or ethylating agents such as dimethyl sulfate, diethyl sulfate, methyl iodide,
ethyl iodide, methyl bromide, methyl chloride, ethyl bromide, ethyl chloride, methyl or
ethyl C1-C6-alkylsulfonate, or the methyl or ethyl esters of the aforementioned
phenylsulfonic acids. A very particularly preferred methylating agent is dimethyl sulfate.
In the process according to the invention, the alkylating agent can be used either in an
equimolar amount based on the compound I, or in a substoichiometric amount or
superstoichiometric amount. Typically, at least an equimolar amount of alkylating agent
VI based on the compound I is used. The molar ratios in which the compound I where
R1 = hydrogen is used relative to alkylating agent VI are in the range from 1:1 to 1:3,
preferably from 1:1 to 1:1.3, for the ratio of compound I to alkylating agent VI.
Typically, the alkylation is performed in the presence of a base. Useful bases are in
principle all compounds which are capable of deprotonating the lactam nitrogen atom.
Suitable bases are, for example, the bases mentioned in connection with the
preparation of the compound I by reacting II with III. The base is preferably selected
from alkali metal and alkaline earth metal hydroxides such as sodium hydroxide,
potassium hydroxide and lithium hydroxide, alkali metal and alkaline earth metal oxides
such as calcium oxide, alkali metal and alkaline earth metal carbonates such as lithium
carbonate, sodium carbonate, potassium carbonate, cesium carbonate, magnesium
carbonate, calcium carbonate, zinc carbonate or barium carbonate. In a particularly
preferred embodiment of the process according to the invention, the base used is
sodium hydroxide or potassium carbonate.
The base can be used in a substoichiometric, superstoichiometric or equimolar amount
based on the compound I. Preference is given to using at least an equimolar amount of
base based on the compound I. The amount of base will generally not be more than
1.3 mol based on 1 mol of the compound I.
The reaction of the compounds I where R1 = hydrogen with the alkylating agent of the
formula VI is advantageously performed in the presence of a solvent. Depending on the
temperature range, the solvents used for these reactions are aliphatic, cycloaliphatic or
aromatic hydrocarbons such as pentane, hexane, cyclopentane, cyclohexane, toluene,
xylene, chlorinated aliphatic and aromatic hydrocarbons such as dichloromethane,
trichloromethane, 1,2-dichloroethane, 1,1,2,2-tetrachloroethane, chiorobenzene, 1,2-,
1,3- or 1,4-dichlorobenzene, chlorotoluenes, dichlorotoluenes, open-chain dialkyl
ethers such as diethyl ether, di-n-propyl ether, di-n-isopropyl ether, methyl tert-butyl
ether, cyclic ethers such as tetrahydrofuran, 1,4-dioxane, anisole, glycol ethers such as
dimethyl glycol ether, diethylene glycol ether, diethylene glycol dimethyl ether,
diethylene glycol diethyl ether, C1-C4-alcohols such as methanol, ethanol, n-propanol,
isopropanol, n-butanol, ketones such as acetone, methyl ethyl ketone, methyl isopropyl
ketone, methyl isobutyl ketone, butanone, carbonates such as diethyl carbonate and
ethylene carbonate, N,N-dialkylamides such as N,N-dimethylformamide or N,N-
dimethylacetamide, N-alkyllactams such as N-methylpyrrolidone, sulfoxides such as
dimethyl sulfoxide, tetralkylureas such as tetramethylurea, tetraethylurea,
tetrabutylureas, dimethylethyleneurea, dimethylpropyleneurea, or mixtures of these
solvents. Preferred solvents are N,N-dimethylformamide, N-methylpyrrolidone,
acetone, dichloromethane, tetrahydrofuran, toluene or mixtures of these solvents.
The alkylation of the compound I is preferably performed at temperatures between -5°C
and 100°C, preferably at temperatures between 0°C and 80°C and especially at
temperatures between 20°C and 50°C. The reaction time can be determined by the
person skilled in the art in a manner familiar per se by routine methods such as thin-
layer chromatography or HPLC.
The compound I, alkylating agent VI and base can be added separately,
simultaneously or successively.
Advantageously, the multistage process for preparing the compound I where R1 ^
hydrogen can also be performed as a one-pot reaction. In the reaction of the
carbamates of the formula II with the enamine of the formula III where R1 = hydrogen in
the presence of an excess of base, the uracil salt is formed initially and is then, without
isolation or purification, reacted with the alkylating agent of the formula VI. Thereafter,
the reaction is conducted to completion within the specified temperature range.
In another variant of the process according to the invention, the reaction can also be
performed in an aqueous multiphasic system, preferably in the presence of phase
transfer catalysts such as quaternary ammonium salts or phosphonium salts. Suitable
quaternary ammonium salts comprise tetraalkyl(C1-C18)ammonium chlorides, bromides,
fluorides or tetrafluoroborates, such as tetraethylammonium chloride,
tetrabutylammonium bromide, tetrabutylammonium iodide, tetrabutylammonium
tetrafluoroborate, N-benzyltrialkyl(C1-C18)ammonium chlorides, bromides or fluorides
such as benzyltriethylammonium chloride, preferably tetrabutylammonium bromide or
tetrabutylammonium iodide. Suitable phosphonium salts are, for example,
tetraphenylphosphonium chloride or bromide, tetraalkyl(C1-C18)phosphonium chloride
or bromide such as tetrabutylphosphonium bromide. In general, the phase transfer
catalyst is used in an amount of up to 20 mol%, preferably between 1 and 15 mol% and
in particular between 2 and 12 mol%, based on the compound I where R1 = hydrogen.
The multiphasic system comprises an aqueous phase and at least one organic liquid
phase. In addition, solid phases may also occur in the course of the reaction. The
aqueous phase is preferably a solution of alkali metal or alkaline earth metal
hydroxides or carbonates in water. With regard to suitable alkali metal or alkaline earth
metal hydroxides or carbonates, reference is made to the statements above. Particular
preference is given to using alkali metal or alkaline earth metal hydroxides, especially
sodium hydroxide. Useful solvents for the organic phase are preferably aliphatic,
cycloaliphatic or aromatic, optionally halogenated hydrocarbons, cyclic or open-chain
ethers or mixtures thereof, reference being made to the statements above with regard
to the aliphatic, cycloaliphatic or aromatic, optionally halogenated hydrocarbons, cyclic
or open-chain ethers. In a preferred embodiment of the process according to the
invention, the multiphasic system consists of aqueous sodium hydroxide solution as the
aqueous phase and of toluene and tetrahydrofuran or dichloromethane and
tetrahydrofuran as the organic phase.
When a multiphasic system is used, it is possible, for example, to initially charge the
compound I in one of the aforementioned organic solvents or solvent mixtures.
Thereafter, the aqueous solution of the base, the alkylating agent VI and the phase
transfer catalyst is added with mixing and then the reaction is brought to completion
within the temperature range specified.
The reaction can be performed at standard pressure, reduced pressure or under
elevated pressure, if appropriate under inert gas, continuously or batchwise.
In particular, it is possible by this route to prepare 3-phenyluracils of the formula I.A.1
where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl,
C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or
phenyl-C1-C4-alkyl; and
Rb and Rd are each hydrogen
¦ by reacting corresponding carbamates of the formula II.A.1

where Rb and Rd are each hydrogen
with enamines of the formula III

where R1 is hydrogen; and
X2 is oxygen,
and
then alkylating the 3-phenyluracil of the formula I.A.1 thus formed,
where R1, Rb and Rd are each hydrogen,
with an alkylating agent of the formula VI

where R1 is C1-C5-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl,
C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl
or phenyl-C1-C4-alkyl, and
L4 is a nucleophilically displaceable leaving group,
preferably the definitions specified above as preferred;
to give 3-phenyluracils of the formula I.A.1
where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl,
C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl
or phenyl-C1-C4-alkyl; and
Rb and Rd are each hydrogen:
I.A.1
where Rb and R" = H
L1 is a nucleophilically displaceable leaving group,
preferably C1-C6-alkoxy or C1-C6-alkylthio,
more preferably C1-C6-alkoxy,
especially preferably C1-C4alkoxy,
very preferably methoxy or ethoxy;
L2 is a nucleophilically displaceable leaving group;
preferably C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy,
C1-C4-alkylthio-C2C4-alkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy,
C3-C6-alkynyloxy, C3-C6-haloalkynyloxy, C3-C8-cycloalkyloxy,
C1-C6-cyanoalkoxy or benzyloxy,
which may itself be partially or fully halogenated on the phenyl ring and/or
be substituted by from one to three radicals from the group of cyano, nitro,
C1-C4-alkyl, C1-C4-alkoxy and C1-C4-alkylthio;
preferably C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy,
C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C3-C6-alkynyloxy or
C3-C6-haloalkynyloxy;
very preferably C1-C6-alkoxy, C1-C4alkoxy-C1-C4alkoxy, C2-C6-alkenyloxy or
C3-C6-alkynyloxy;
exceptionally preferably C1-C6-alkoxy.
Preference is given to the preparation especially of those 3-phenyluracils of the formula
I.A.1 where Rb and Rd = hydrogen, in which the variables R1, R2, R3, Ra, Rc, and also
R4 and R5, each alone or in combination with one another, are defined as follows:
R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl,
C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl;
very preferably C1-C4-alkyl,
more preferably methyl or ethyl,
especially preferably methyl;
R2 is hydrogen, C1-C4-alkyl or C1-C4-haloalkyl,
more preferably hydrogen, methyl, difluoromethyl or trifluoromethyl,
especially preferably trifluoromethyl;
R3 is hydrogen or C1-C4-alkyl,
more preferably hydrogen.
Ra is hydrogen, halogen or cyano,
especially preferably hydrogen, fluorine, chlorine or cyano,
very preferably hydrogen, chlorine or cyano,
exceptionally preferably hydrogen or chlorine,
very exceptionally preferably hydrogen;
Rc is hydrogen or halogen,
especially preferably hydrogen, fluorine or chlorine,
very preferably hydrogen or fluorine,
exceptionally preferably fluorine;
R4 and R5 are each independently
hydrogen or C1-C4-alkyl which may itself be substituted by a substituent selected
from the group of
halogen, cyano and C1-C4-alkoxy, preferably halogen;
especially preferably
R4 is hydrogen, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl,
very preferably hydrogen or C1-C4-alkyl,
more preferably C1-C4-alkyl,
exceptionally preferably methyl; and
R5 is C1-C6-alkyl, C3-C8-cycloalkyl or phenyl,
very preferably C1-C6-alkyl,
more preferably C1-C4-alkyl.
The introduction of the amino group on the (thio)uracil ring or dithiouracil ring succeeds
surprisingly on the basis of known processes for introducing the amino group on the
uracil nitrogen. Such processes are described, for example, in DE 196 52431, whose
disclosure on electrophilic amination is hereby incorporated fully by reference. Suitable
'aminating agents of the formula VII include, for example, 1-aminooxy-2,4-dinitro-
benzene or O-mesitylenesulfonylhydroxylamine.
If appropriate, the reaction is effected in the presence of a base. Useful bases include
all customary inorganic or organic bases. Suitable bases are, for example, the bases
mentioned in connection with the preparation of the compound I by reacting II with III.
Preferred bases are alkali metal alkoxides, especially lithium, sodium or potassium
alkoxides such as sodium methoxide, sodium ethoxide, lithium ethoxide, potassium
methoxide, potassium ethoxide, potassium tert-butoxide, sodium tert-butoxide, sodium
isopropoxide, potassium tert-pentoxide, alkali metal hydrides such as sodium hydride,
potassium hydride, alkali metal carbonates such as lithium carbonate, sodium
carbonate, potassium carbonate, cesium carbonate or tertiary amines, especially
amidine bases such as 1,8-diazabicyclo[5.4.0]undec-7-ene. In general, the compound I
where R1 = hydrogen and the base are used in approximately equimolar amounts.
The reaction of the compound I where R1 = hydrogen with an aminating reagent of the
formula VII is effected generally in an inert organic solvent or solvent mixture. Solvents
preferred for this purpose are nitriles such as acetonitrile, propionitrile or butyronitriie,
ketones such as acetone and methyl ethyl ketone, carbonates such as dimethyl
carbonate, diethyl carbonate and ethylene carbonate, and also amides such as
N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidone. Also
suitable are organic solvents having basic character, for example the aforementioned
tertiary amines such as trialkylamines and pyridine compounds.
In general, the reaction will be performed at temperatures of from 0 to 80°C, preferably
between 10 and 60_°C. For this purpose, the compound I where R1 = hydrogen and the
aminating reagent of the formula VII are generally reacted in approximately equimolar
amounts. However, it is also possible to use one of the components in a relatively large
excess, in which case the excess will preferably not be more than 50 mol% based on
the component present in deficiency.
The workup of the reaction mixture to obtain the target product I can be effected by the
methods customary for this purpose. Generally, the solvent used will be removed by
customary processes, for example by distillation. The target compound I can then be
taken up in a water-immiscible organic solvent, any impurities can be extracted with
optionally acidified water, the mixture can be dried and the solvent can be removed
under reduced pressure. For further purification, the customary processes such as
crystallization, precipitation or chromatography can be employed. When a biphasic
system is used, workup will generally be effected by extraction.
Compounds of the formula I where one of the X1, X2 or X3 radicals, or the X1, X2 and X3
radicals, are each oxygen can be converted to compounds of the general formula I
where one of the X1, X2 or X3 radicals, or the X1, X2 and X3 radicals, are each sulfur by
known methods by treating with sulfurizing agents. Examples of suitable sulfurizing
agents are organophosphorus sulfides such as the Lawesson reagent, organotin
sulfides or phosphorus(V) sulfides (see also J. March, Advanced Organic Synthesis,
2nd edition, Wiley Interscience 1985, p. 794 and literature cited there). The reaction
can be performed in a solvent or in bulk. Suitable solvents are the abovementioned
inert solvents, and also basic solvents such as pyridine and comparable solvents. The
temperature required for the reaction is generally above room temperature and is in
particular in the range from 50 to 200°C. When the reaction of the enamine III with an
isothiocyanate II in which the X1 radical is sulfur is performed, the corresponding 2-
thioxouracils where X1 = sulfur are obtained directly.
The carbamates of the formula II required for the preparation of the 3-
phenyl(thio)uracils and -dithiouracils of the formula I are obtainable by reacting an
amine of the formula IV with a compound of the formula V:
The variables X1, X3, Ar, A and L1 are each as defined above, and especially preferably
as defined with preference in the description.
L3 is a nucleophilically displaceable leaving group,
preferably chlorine or C1-C6-alkoxy;
more preferably chlorine.
The amines of the formula IV are reacted with compounds of the formula V typically at
temperatures of from -10°C to 160°C, preferably from 0°C to 130°C, very preferably
from 25°C to 130°C, in an inert organic solvent, if appropriate in the presence of a base
(for example Houben-Weyl, Methoden der organischen Chemie, E5, 1985, p. 972-980,
and also VIII, p. 655 and XI Part 2, p. 10).
The reaction pressure is of minor importance for the success of the process according
to the invention and may, for example, be in the range from 500 mbar to 10 bar.
Preference is given to carrying out the reaction in the region of standard pressure, i.e.
in the range from 0.9 to 1.2 bar.
The reaction time required for the reaction is generally in the range from 1h to 24h, and
in particular in the range from 2h to 8h.
The reaction may in principle be carried out in substance. However, preference is given
to reacting the amines of the formula IV with the compounds of the formula V in an /
organic solvent. Suitable in principle are all solvents which are capable of dissolving J
the compounds IV and V at least partly and preferably fully under reaction conditions. '
Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane
and mixtures of C5-C8-alkanes, aromatic hydrocarbons such as toluene, o-, m- and p-
xylene, halogenated hydrocarbons such as methylene chloride, chloroform and
chlorobenzene, ethers such as diethyl ether, diisopropyl ether, tert-butyl methyl ether,
dioxane, anisole and tetrahydrofuran, carboxylic esters such as butyl acetate, more
preferably halogenated hydrocarbons and ethers.
It is also possible to use mixtures of the solvents mentioned.
The reaction of the amines of the formula IV with compounds of the formula V may be
carried out in the presence of a base, but it is not necessary to use a base.
Useful bases are generally inorganic compounds such as alkali metal and alkaline
earth metal hydroxides such as lithium hydroxide, sodium hydroxideT'p^dtSSSitfm
hydroxide and calcium hydroxide, alkali metal amides such as lithium amide, sodium
amide and potassium amide, alkali metal and alkaline earth metal carbonates such as
lithium carbonate, potassium carbonate and calcium carbonate, and also alkali metal
hydrogencarbonates such as sodium hydrogencarbonate, and also alkali metal and
alkaline earth metal alkoxides such as sodium methoxide, sodium ethoxide, potassium
ethoxide, potassium tert-butoxide, potassium tert-pentoxide and dimethoxymagnesium,
and also organic bases, for example tertiary amines such as trimethylamine,
triethylamine, diisopropylethylamine, N-methylpiperidine and N-methylmorpholine,
pyridine, substituted pyridines such as picoline, collidine, lutidine and 4-
dimethylaminopyridine, and also bicyclic amines. Particular preference is given to
organic bases such as triethylamine, pyridine and picoline.
The bases are generally used in equimolar amounts, but they may also be used
catalytically, in excess or, if appropriate, as the solvent.
In a preferred variant of the process according to the invention, the amines of the
formula IV are reacted with compounds of formula V in the absence of a base.
Some of the advantages of this preferred variant of the reaction are that a complicated
'workup after the end of the reaction is dispensed with and the further reaction of the
carbamates II thus prepared to give 3-phenyl(thio)uracils and -dithiouracils I, preferably
3-phenyluracils LA. 1, in which case the aforementioned chlorination of the carbamate II
can also be performed if appropriate, can be effected as a one-pot reaction or entails
only one solvent exchange.
The reactants are generally reacted with one another in equimolar amounts. It may be
advantageous to use V in an excess based on IV. Preference is given to using the
compounds in a molar IV:V ratio in the range from 1.6:1 to 1:1.6, in particular from
1:1.4 to 1:1.
Preference is given to removing the compound L3-H formed in the reaction of the
amines of the formula IV with the compounds of the formula V from the reaction
mixture during the reaction to an extent of at least 80%, especially when the compound
L3-H is a C1-C4-alkanol such as methanol or ethanol.
To this end, the reaction will be carried out in a manner known per se at a temperature
and a pressure at which the compound L3-H, if appropriate, is distilled out of the
reaction mixture as an azeotrope with the solvent. If appropriate, fresh solvent will be
introduced into the reaction for compensation or the solvent distilled off with the
compound L3-H, if appropriate after distillative depletion of the compound L3-H, will be
recycled into the reaction.
For these reasons, it is advantageous when the solvent used has a boiling point of at
least 10°C and in particular at least 30°C above the boiling point of the compound L3-H
formed in the reaction (each at standard pressure).
Appropriately, the reaction of the amines of the formula IV with the compounds of the
formula V is carried out in an apparatus which is equipped with at least one distillation
and rectification apparatus, for example a distillation column, which firstly allows the
compound L3-H, if appropriate together with the solvent, to be distilled off and
simultaneously enables removal and recycling of any solvent distilled off with the
compound L3-H.
For the reaction, the amines of the formula IV may be contacted with the compounds of
the formula V and, if appropriate, the base in any desired manner, i.e. the reactants
and, if appropriate, the base may be introduced into the reaction vessel separately,
simultaneously or successively and reacted. For example, the amines IV and the
compounds V may be initially charged in a reaction vessel, if appropriate with the
desired solvent, and then the desired reaction conditions can be attained.
However, it is also possible to introduce the majority or entirety of amine IV and
¦ compound V, if appropriate in a solvent, under reaction conditions into the reaction
vessel.
In a particularly preferred embodiment, the amine IV is initially charged and then, if
appropriate, the base and thereafter the compound V are added.
In a particularly preferred embodiment of the invention, the majority, in particular at
least 80% and more preferably the entirety or virtually the entirety (> 95%) of the
amines of the formula IV are initially charged and the majority, in particular at least 80%
and more preferably the entirety or virtually the entirety (> 95%) of the compounds of
the formula V are added thereto under reaction conditions in the course of the reaction,
for example over a period of from 0.5 to 20 h and in particular from 1 to 10 h. To this
end, the compounds of the formula V will preferably be dissolved in a solvent. If
appropriate, a certain continued reaction time, for example from 1 h to 10 h, in
particular from 2 h to 5 h, will be allowed after the addition of the compounds of the
formula V.
The carbamates of the formula II can be worked up and isolated in a manner known
per se.
In particular, it is possible by this route to prepare carbamates of the formula II.A.1

where Rb and Rd are each hydrogen
by reacting corresponding amines of the formula IV.A.1

where Rb and Rd are each hydrogen
with compounds V

where X1 is oxygen:

L3 is a nucleophilically displaceable leaving group,
preferably chlorine or C1-C6-alkoxy;
more preferably chlorine.
Preference is given to the preparation especially of those carbamates of the formula
II.A.1 where Rb and Rd = hydrogen in which the variables L1, Ra, Rc and also R4and R5,
each alone and also in combination with one another, are defined as follows:
L1 is a nucleophilically displaceable leaving group,
preferably C1-C6-alkoxy or C1-C6-alkylthio,
more preferably C1-C6-alkoxy,
especially preferably C1-C4alkoxy,
very preferably methoxy or ethoxy;
Ra is hydrogen, halogen or cyano,
especially preferably hydrogen, fluorine, chlorine or cyano,
very preferably hydrogen, chlorine or cyano,
exceptionally preferably hydrogen or chlorine,
very exceptionally preferably hydrogen;
Rc is hydrogen or halogen,
especially preferably hydrogen, fluorine or chlorine,
very preferably hydrogen or fluorine,
exceptionally preferably fluorine;
R4 and R5 are each independently
hydrogen or C1-C6-alkyl which may in turn be substituted by a substituent
selected from the group of
halogen, cyano and C1-C4-alkoxy, preferably halogen;
especially preferably
R4 is hydrogen, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl,
very preferably hydrogen or C1-C6-alkyl,
more preferably C1-C4-alkyl,
exceptionally preferably methyl; and
R5 is C1-C6-alkyl, C3-C8-cycloalkyl or phenyl,
very preferably C1-C6-alkyl,
more preferably C1-C4-alkyl.
The amines of the formula IV required for the preparation of the carbamates of the
formula II are disclosed jnjhe literature (for example WO 04/039768) or can be
prepared in accordance with the cited literature.
The compounds of the formula V required for the preparation of the carbamates of the
formula II are disclosed in the literature (for example Houben-Weyl, Methoden der
organischen Chemie, E4, 1983, p. 6-17) and can be purchased commercially or
prepared in accordance with the cited literature.
The carbamates of the formula II prepared by this route may subsequently, if desired,
be halogenated on the Ar radical in an intermediate step before the reaction with the
enamines of the formula III.
The carbamates of the formula II prepared by this route may preferably be chlorinated
or brominated, very preferably chlorinated, on the Ar radical in a further step.
The halogenation is effected typically at temperatures of from 0°C to 100°C, preferably
from 20°C to 70°C, in an inert organic solvent, if appropriate in the presence of a
catalyst (for example Buehler, Peason, Survey of Organic Synthesis, Interscience
Publishers 1970, p. 392-404).
The reaction pressure is of minor importance for the success of the process according
to the invention and may, for example, be in the range from 500 mbar to 10 bar.
Preference is given to carrying out the reaction in the region of standard pressure, i.e.
in the range from 0.9 to 1.2 bar.
The reaction time required for the reaction is generally in the range from 1 h to 24 h,
and in particular in the range from 3 h to 12 h.
'The reaction may in principle be carried out in substance. However, preference is given
to reacting the carbamates of the formula V with the halogenating agent in an organic
solvent. Suitable in principle are all solvents which are capable of dissolving the
compound V at least partly and preferably fully under reaction conditions.
Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane
and mixtures of C5-C8-alkanes, halogenated hydrocarbons such as methylene chloride,
chloroform, butyl chloride and chlorobenzene, ethers such as diethyl ether, diisopropyl
ether, tert-butyl methyl ether, dioxane, anisole and tetrahydrofuran, nitriles such as
acetonitrile and propionitrile, ketones such as acetone, methyl ethyl ketone, diethyl
ketone and tert-butyl methyl ketone, carboxylic acids such as formic acid or acetic acid,
esters such as butyl acetate or dimethyl carbonate, and also sulfuryl chloride, more
preferably halogenated hydrocarbons and sulfuryl chloride.
It is also possible to use mixtures of the solvents mentioned.
The halogenating agents required for the halogenation are disclosed in the literature
(for example Buehler, Peason, Survey of Organic Synthesis, Interscience Publishers
1970, p. 392-404) or can be prepared in accordance with the cited literature.
Examples of halogenating agents which find use are chlorine, N-chlorosuccinimide,
S02CI2, HCI/H202) 1,3-dichloro-5,5-dimethylhydantoin, bromine, N-brornosuccinimide,
HBr/H202 or 1,3-dibromo-5,5-dimethylhydantoin.
The halogenation of the carbamates of the formula II may, depending upon the
halogenating agent selected, be carried out in the presence of a catalyst.
Examples of catalysts which find use are Lewis acids such as boron trifluoride,
aluminum trichloride, iron(lll) chloride, tin(IV) chloride, titanium(IV) chloride and zinc(ll)
chloride.
The halogenating agent is generally used in an equimolar amount, but it may also be
used in deficiency, in excess, or, if appropriate, as the solvent.
The halogenated carbamates of the formula II can be worked up and isolated in a
manner known per se.
It may be advantageous to partly or fully scavenge the by-products formed in the
reaction from the halogenating reagent by addition of a suitable base.
In particular, it is possible in this way to prepare para-chlorinated carbamates of the
formula II.A.1
where Ra = chlorine and Rb and Rd = hydrogen
by chlorinating corresponding carbamates of the formula II.A.1
where Ra, Rb and Rd = hydrogen:

Preference is given to the chlorination especially of those carbamates of the formula
II.A.1 where Ra, Rb and Rd = hydrogen in which the variables L1, Rc and also R4 and R5,
each alone and also in combination with one another, are defined as follows:
L1 is a nucleophilically displaceable leaving group,
preferably C1-C6-alkoxy or C1-C6-alkylthio,
more preferably C1-C6-alkoxy,
especially preferably C1-C4-alkoxy,
very preferably methoxy or ethoxy;
Rc is hydrogen or halogen,
especially preferably hydrogen, fluorine or chlorine,
very preferably hydrogen or fluorine,
exceptionally preferably fluorine;
R4 and R5 are each independently
hydrogen or C1-C6-alkyl which may in turn be substituted by a substituent
selected from the group of
halogen, cyano and C1-C4-alkoxy, preferably halogen;
especially preferably
R4 is hydrogen, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl,
very preferably hydrogen or C1-C6-alkyl,
more preferably C1-C4-alkyl,
exceptionally preferably methyl; and
R5 is C1-C6-alkyl, C3-C8-cycloalkyl or phenyl,
very preferably C1-C6-alkyl,
more preferably C1-C6-alkyl.
The reaction described here of the amines of the formula IV with compounds of the
formula V affords the carbamates of the formula II in high yield.
A further preferred embodiment therefore relates to a process in which the amines of
the formula IV are reacted in a first step with compounds of the formula V to give
carbamates of the formula II, and the carbamates of the formula II are subsequently
reacted without isolation with the enamines of the formula III to give 3-phenyl(thio)-
uracils and -dithiouracils of the formula I. To this end, it may be advantageous when a
portion or the entirety of the solvent used to prepare the carbamate of the formula II is
removed and substituted by another solvent. However, the reaction of the carbamates
of the formula II with the enamines of the formula III will in particular be carried out in
the solvent used to prepare the carbamate of the formula II.
The following steps of the process according to the invention are specified as
especially preferred, the preference applying both to each individual step and to the
overall process. The preferred embodiments of the following steps are as specified
above.
In one embodiment of the process according to the invention, it is possible to prepare
3-phenyluracils of the formula I.A.1 where R1 is C1-C4-alkyl, C1-C4-cyanoalkyl, C1-C6-
haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-
haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen; by reacting
corresponding carbamates of the formula II.A.1 where Ra is chlorine and Rb and Rd are
each hydrogen with enamines of the formula III where R1 is hydrogen; and X2 is
oxygen,
and then alkylating the 3-phenyluracil of the formula I.A.1 thus formed, where Ra is
chlorine and R1, Rb and Rd are each hydrogen with an alkylating agent of the formula VI
where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C4-haloalkyl, C3-C8-cycloalkyl, C2-C6-
alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl, and
L4 is a nucleophilically displaceable leaving group to give 3-phenyluracils of the formula
I.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C4-haloalkyl, C3-C8-cycloalkyl, C2-
C6-alkenyl, C2-d6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl;
and Rb and Rd are each hydrogen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula I.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl,
C1-C4-haloalkyl, C3-C8-cycloalkyl, C1-C4-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-
d-haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen; by reacting
corresponding carbamates of the formula II.A.1 where Ra is chlorine and Rb and Rd are
each hydrogen with enamines of the formula III where R1 is C1-C4-alky!, C1-C4-
cyanoalkyl, C1-C4-haloalkyl, C1-C4-cycloalkyl, C1-C4-alkenyl, C2-C6-haloalkenyl, C3-C6-
alkynyl, C3-C6-naloalkynyl or phenyl-C1-C4-alkyl, and X2 is oxygen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula I.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl,
C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-
' C6-haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen
by chlorinating carbamates of the formula II.A.1 where Ra, Rb and Rd = hydrogen to
give para-chlorinated carbamates of the formula II.A.1 where Ra = chlorine and Rb and
Rd = hydrogen,
then reacting them with enamines of the formula III where R1 is hydrogen; and X2 is
oxygen,
and then alkylating the 3-phenyluracil of the formula I.A.1 thus formed, where Ra is
chlorine and R\ Rb and Rd are each hydrogen with an alkylating agent of the formula VI
where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-
alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl, and
L4 is a nucleophilically displaceable leaving group to give 3-phenyluracils of the formula
I.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-
C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl;
and Rb and Rd are each hydrogen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula I.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl,
C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-
C6-haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen
by chlorinating carbamates of the formula II.A.1 where Ra, Rb and Rd = hydrogen to
give para-chlorinated carbamates of the formula II.A.1 where Ra = chlorine and Rb and
Rd = hydrogen, and
then reacting them with enamines of the formula III where R1 is C1-C6-alkyl, C1-C4-
cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-
alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl, and X2 is oxygen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula I.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl,
C1-C6-haloalkyl, C3-d8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-
C6-haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen
by reacting corresponding amines of the formula IV.A.1 where Ra, Rb and Rd are each
hydrogen with compounds V where X1 is oxygen;
then chlorinating the carbamates of the formula II.A.1 thus obtained, where Ra, Rb and
Rd = hydrogen, to give para-chlorinated carbamates of the formula II.A.1 where Ra =
chlorine and Rb and Rd = hydrogen,
then reacting them with enamines of the formula III where R1 is hydrogen; and X2 is
oxygen,
and then alkylating the 3-phenyluracil of the formula I.A.1 thus formed, where Ra is
chlorine and R1, Rb and Rd are each hydrogen with an alkylating agent of the formula VI
where R1 is Ci-Ce-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-
alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl, and
L4 is a nucleophilically displaceable leaving group to give 3-phenyluracils of the formula
'l.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-
Ce-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl;
and Rb and Rd are each hydrogen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula l.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl,
C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-
C6-haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen
by reacting corresponding amines of the formula IV.A.1 where Ra, Rb and Rd are each
hydrogen with compounds V where X1 is oxygen;
then chlorinating the carbamates of the formula II.A.1 thus obtained, where Ra, Rb and
Rd = hydrogen, to give para-chlorinated carbamates of the formula II.A.1 where Ra =
chlorine and Rb and Rd = hydrogen, and
then reacting them with enamines of the formula III where R1 is C1-C6-alkyl, C1-C4-
cyanoalkyl, C1-C4-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-
alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl, and X2 is oxygen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula l.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl,
C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-
Ce-haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen
by reacting corresponding amines of the formula IV.A.1 where Ra = chlorine and Rb and
Rd are each hydrogen with compounds V where X1 is oxygen;
then reacting the carbamates of the formula II.A.1 thus obtained, where Ra = chlorine
and Rb and Rd = hydrogen, with enamines of the formula III where R1 is hydrogen; and
X2 is oxygen,
and then alkylating the 3-phenyluracil of the formula l.A.1 thus formed, where Ra is
chlorine and R1, Rb and Rd are each hydrogen, with an alkylating agent of the formula
VI where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-
alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl, and
L4 is a nucleophilically displaceable leaving group to give 3-phenyluracils of the formula
l.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-
C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl;
and Rb and Rd are each hydrogen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula l.A.1 where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl,
C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-
C6-haloalkynyl or phenyl-C1-C4-alkyl; and Rb and Rd are each hydrogen
by reacting corresponding amines of the formula IV.A.1 where Ra = chlorine and Rb and
Rd are each hydrogen with compounds V where X1 is oxygen; and
then reacting the carbamates of the formula II.A.1 thus obtained, where Ra = chlorine
and Rb and Rd = hydrogen, with enamines of the formula III where R1 is C1-C4-alkyl, C1-
C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-
C6-alkynyl, C3-C6-haloalkynyl or phenyl-C1-C4-alkyl, and X2 is oxygen.
In a further embodiment of the process according to the invention, it is possible to
prepare 3-phenyluracils of the formula I.A.1 where R1, Rb and Rd are each hydrogen;
by reacting corresponding amines of the formula IV.A.1 where Ra = chlorine and Rb and
Rd are each hydrogen with compounds V where X1 is oxygen; and
then reacting the carbamates of the formula II.A.1 formed, where Ra is chlorine and Rb
and Rd are each hydrogen, with enamines of the formula III where R1 is hydrogen.
The process according to the invention allows for the first time the preparation of
carbamates of the formula II
where X1 and X3 and also Ar and A are each as defined above and
L1 is a nucleophilically displaceable leaving group, preferably C1-C6-alkoxy or C1-C6-
alkylthio, more preferably C1-C6-alkoxy.
These compounds are novel and likewise form part of the subject-matter of the present
invention.
Among the carbamates of the formula II, preference is given to those of the formula II.A
(= carbamates of the formula II where X1 and X3 are each oxygen and Ar is Ar-1)

where the variables Ra, Rb, Rc and Rd and also A and L1 are each as defined above.
Very particular preference is given to the carbamates of the formula II.A.1
(= carbamates of the formula II, where X1 and X3 are each oxygen, Ar is Ar-1 and A is
NR4R5)

where the variables Ra, Rb, Rc and Rd and also R4, R5 and L1 are each as defined
above.
Among the carbamates of the formula II.A.1, preference is given in particular to those
in which the variables L1, Ra, Rb, Rc and Rd and also R4 and R5, each alone or in
combination, are defined as follows:
L1 nucleophilically displaceable leaving group,
preferably C1-C6-alkoxy or C1-C6-alkylthio,
more preferably C1-C6-alkoxy,
especially preferably C1-C4-alkoxy,
very preferably methoxy or ethoxy;
Ra is hydrogen, halogen or cyano,
especially preferably hydrogen, fluorine, chlorine or cyano,
very preferably hydrogen, chlorine or cyano,
exceptionally preferably hydrogen or chlorine;
Rb hydrogen;
Rc hydrogen or halogen,
especially preferably hydrogen, fluorine, or chlorine,
very preferably hydrogen or fluorine,
exceptionally preferably fluorine;
Rd hydrogen;
R4 and R5 each independently
hydrogen or C1-C6-alkyl which may itself be substituted by one substitutent
selected from the group of
halogen, cyano and C1-C4-alkoxy, preferably halogen;
especially preferably
R4 hydrogen, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl,
very preferably hydrogen or C1-C6-alkyl,
more preferably C1-C4-alkyl,
exceptionally preferably methyl; and
R5 C1-C6-alkyl, C3-C8-cycloalkyl or phenyl,
very preferably C-,-C6-alkyl,
more preferably C1-C4-alkyl.
Exceptional preference is given to the carbamates of the formula II.A.1 .a
(corresponding to carbamates of the formula II where L1 = methoxy, X1, X3 = oxygen,
Ar = Ar-1 where Rb and Rd = hydrogen and Rc = fluorine, and A = NR4R5), especially
the carbamates of the formula II.A.1.a. 1 to II.A.1.a.60 of Table 1, the definitions of the
variables Ra, R4 and R5 play a particular role for the inventive compounds not only in
combination with one another but also in each case viewed alone.
Equally exceptionally preferred are the carbamates of the formula IIAI.b, especially
the compounds of the formula II.A.1.b.1 to II.A.1.b.60 which differ from the
corresponding compounds of the formula II.A.1.a.1 to II.A.1.a.60 in that L1 is ethoxy.
Equally exceptionally preferred are the carbamates of the formula II.A.1.C, especially
the compounds of the formula II.A.1.C.1 to II.A.1.C.60 which differ from the
corresponding compounds of the formula II.A.1.a.1 to II.A.1.a.60 in that L1 is
n-propyloxy.
Equally exceptionally preferred are the carbamates of the formula II.A.I.d, especially
the compounds of the formula II.A.I.d.1 to II.A.1.d.60 which differ from the
corresponding compounds of the formula II.A.1.a.1 to II.A.1.a.60 in that L1 is
isopropyloxy.
Equally exceptionally preferred are the carbamates of the formula II.A.I.e, especially
the compounds of the formula II.A.1.e.1 to II.A.1.e.60 which differ from the
corresponding compounds of the formula II.A.1.a.1 to II.A.1.a.60 in that L1 is
sec-butyloxy.
Equally exceptionally preferred are the carbamates of the formula IIAI.f, especially
the compounds of the formula IIAI.f. 1 to IIAI.f.60 which differ from the
corresponding compounds of the formula II.A.1.a.1 to II.A.1.a.60 in that L1 is
isobutyloxy.
Equally exceptionally preferred are the carbamates of the formula II.A.I.g, especially
the compounds of the formula II.A.I.g.1 to II.A.I.g.60 which differ from the
corresponding compounds of the formula IIA1.a.1 to II.A.1.a.60 in that L1 is
tert-butyloxy.
Equally exceptionally preferred are the carbamates of the formula II.A.I.h, especially
the compounds of the formula II.A.I.h.1 to II.A.I.h.60 which differ from the
corresponding compounds of the formula IIAI.a.1 to IIA1.a.60 in that L1 is
methylthio.
Equally exceptionally preferred are the carbamates of the formula IIAI.i, especially
the compounds of the formula IIA111 to IIA1.L60 which differ from the
corresponding compounds of the formula II.A.la.1 to II.A.1.a.60 in that L1 is ethylthio.
Synthesis examples
The examples which follow serve to illustrate the invention.
1. Preparation of the carbamates of the formula II
Example 1.1:
N-(4-Fluoro-3-r(ethoxvcarbonvl)aminolbenzoyl)-N'-/sopropvl-N'-methvlsulfamide
(Compound II.A.1.b.15)
Example 1.1 .a
14.13 g (0.179 mol) of pyridine were added dropwise at room temperature to a solution
of 41.0 g (0.138 mol) of N-(4-fluoro-3-aminobenzoyl)-NVsopropyl-N'-methylsulfamide in
methylene chloride and the mixture was subsequently cooled to 0-5°C. At this
temperature, 19.83 g (0.183 mol) of ethyl chloroformate in methylene chloride were
added in portions and the mixture was subsequently stirred for 60 min. The reaction
mixture was hydrolyzed and the removed organic phase was extracted with H20 and
10% hydrochloric acid. Subsequently, the organic phase was washed and dried, and
. the solvent was removed.
47.9 g (96% of theory) of the title compound were obtained (m.p.: 142-144°C)
1H NMR (500 MHz, C1-C4MSO) d[ppm] = 11.9 (s, 1H), 9.50 (s, 1H), 8.30 (d, 1H), 7.65-
7.70 (m, 1H), 7.35 (t, 1H), 4.10-4.25 (m, 3H), 2.90 (s, 3H), 1.28 (t, 3H), 1.10 (d, 6H).
Analogously to Example 1.1.a, the following examples 1.1.b to 1.1.e were carried out:
Example 1.1 .b
6.10 g (0.020 mol) of N-(4-fluoro-3-aminobenzoyl)-N,-/sopropyl-N'-
methylsulfamide
3.87 g (0.041 mol) of picoline
2.97 g (0.027 mol) of ethyl chloroformate
6.1 g (95% of theory) of the title compound were obtained.
Example 1.1.c
6.00 g (0.020 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/sopropyl-N'-
methylsulfamide
2.47 g (0.062 mol) of NaOH
2.97 g (0.027 mol) of ethyl chloroformate
6.4 g (95% of theory) of the title compound were obtained.
Example 1.1.d
6.00 g (0.020 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/'sopropyl-N'-
methylsulfamide
3.72 g (0.027 mol) of K2C03
3.00 g (0.027 mol) of ethyl chloroformate
6.0 g (76% of theory) of the title compound were obtained.
Example 1.1 .e
5.90 g (0.020 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/sopropyl-N'-
methylsulfamide
2.47 g (0.062 mol) of triethylamine
0.24 g (0.062 mol) of dimethylaminopyridine (DMAP)
2.89 g (0.027 mol) of ethyl chloroformate
6.1 g (52% of theory) of the title compound were obtained.
Example 1.1.f
134.7 g (1.22 mol) of ethyl chloroformate were added in portions at 115-125°C to a
solution of 300.0 g (0.897 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/sopropyl-N'-
methylsulfamide in chlorobenzene and the mixture was subsequently stirred at 125°C
for 2 h. Afterward, the solvent and the excess ethyl chloroformate were removed.
312.8 g (96% of theory) of the title compound were obtained.
Example 1.2
N-{6-Chloro-4-fluoro-3-r(ethoxvcarbonvl)amino1benzovl}-N'-/sopropyl-N'-
methvlsulfamide
(Compound II.A.1.b.45)

57.7 g (0.729 mol) of pyridine were added dropwise at room temperature to a solution
of 200.0 g (0.565 mol) of N-(6-chloro-4-fluoro-3-aminobenzoyl)-N'-/sopropyl-N'-
methylsulfamide in methylene chloride and the mixture was subsequently cooled to
0-5°C. Subsequently, 80.99 g (0.746 mol) of ethyl chloroformate in methylene chloride
were added in portions and the mixture was left to stir for 60 min. The reaction mixture
was then hydrolyzed and the removed organic phase was extracted with H20 and 10%
hydrochloric acid. Subsequently, the organic phase was washed and dried, and the
solvent was removed.
156.4 g (86% of theory) of the title compound were obtained.
1H NMR (400 MHz, CDCI3): 5 = 8.70 (s, 1 H), 8.45 (d, 1 H), 7.20 (d, 1 H), 6.90 (s, 1H)
4.20-4.40 [m, 3 H), 3.00 (s, 3H), 1.35 (t, 3H), 1.20 (d, 6H).
Example 1.3
N-{4-Fluoro-3-r(methoxvcarbonvl)amino1benzovl)-N'-isopropyl-N'-methvlsulfamide
(Compound II.A.1.a.15)
5.52 g (0.057 mol) of methyl chloroformate were added in portions at 115-125°C to a
solution of 12.50 g (0.042 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/sopropyl-N'-
methylsulfamide in chlorobenzene, and the mixture was then stirred at 125°C for 2 h.
The solvent and the excess methyl chloroformate were then removed.
14.9 g (99% of theory) of the title compound were obtained.
1H NMR (500 MHz, CDCI3): 5 = 9.25 (s, 1 H), 8.55 (d, 1 H), 7.55-7.60 (m, 1 H), 7.15 (t,
1 H), 6.95 (s, 1 H) 4.20-4.30 (m, 1 H), 3.00 (s, 3 H), 2.95 (s, 3 H), 1.18 ppm (d, 6 H).
Example 1.4
N-(4-Fluoro-3-r(phenoxvcarbonvnamino1benzoyl}-N'-/sopropyl-N'-methvlsulfamide
6.69 g (0.057 mol) of phenyl chloroformate were added in portions at 115-125°C to a
solution of 12.50 g (0.042 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/sopropyl-N'-
methylsulfamide in chlorobenzene, and the mixture was then stirred at 125°C for 2 h.
The solvent and the excess phenyl chloroformate were then removed.
17.7 g (98% of theory) of the title compound were obtained.
1H NMR (500 MHz, CDCI3): 5 = 9.05 (s, 1 H), 8.55 (d, 1 H), 7.55-7.60 (m, 1 H), 7.25-
7.40 (m, 7 H), 4.20-4.30 (m, 1 H), 3.00 (s, 3 H), 1.20 ppm (d, 6 H).
Example 1.5
N-{4-Fluoro-3-[(n-butvloxvcarbonvl)amino1benzovl}-N'-/sopropvl-N'-methvlsulfamide
7.36 g (0.053 mol) of n-butyl chloroformate were added in portions at 115-125°C to a
solution of 12.50 g (0.042 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/'sopropyl-N'-
methylsulfamide in chlorobenzene, and the mixture was then stirred at 125°C for 2 h.
The solvent and the excess n-butyl chloroformate were then removed.
18.0 g (93% of theory) of the title compound were obtained.
1H NMR (500 MHz, CDCI3): 5 = 9.15 (s, 1 H), 8.55 (d, 1 H), 7.55-7.60 (m, 1 H), 7.15 (t,
1 H), 6.95 (s, 1 H), 4.20-4.35 (m, 3 H), 3.00 (s, 3 H), 2.95 (s, 3 H), 1.60 (q, 2 H), 1.35
(q, 2 H), 1.18 ppm (6 H), 0.95 (t, 3 H).
Example 1.6
N-(4-Fluoro-3-r(/sopropvloxvcarbonvl)aminolbenzovl}-N'-/sopropyl-N'-methvlsulfamide
(Compound II.A.1.d.15)
83 g of a 1M solution of isopropyl chloroformate in toluene (corresponds to 0.097 mol
of isopropyl chloroformate) were added in portions at 115-125°C to a solution of
12.50 g (0.042 mol) of N-(4-fluoro-3-aminobenzoyl)-N'-/sopropyl-N'-methylsulfamide in
toluene, and then the mixture was stirred at 125°C for 2 h. The solvent and the excess
/sopropyl chloroformate were then removed.
16.1 g (97% of theory) of the title compound were obtained.
1H NMR (500 MHz, CDCI3): 8 = 9.10 (s, 1 H), 8.55 (d, 1 H), 7.55-7.60 (m, 1 H), 7.10 (t,
1 H), 6.90 (s, 1 H) 4.95-5.10 (m, 1 H), 4.20-4.30 (m, 1 H), 2.95 (s, 3 H), 1.35 (d, 6 H),
1.18 ppm (d, 6 H).
2. Preparation of the chlorinated carbamates of the formula II
Example 2.1:
N-{2-Chloro-4-fluoro-5-[(ethoxycarbonyl)amino]ben2oyl}-N'-/sopropyl-N'-
methylsulfamide
(Compound II.A.1.b.45)

Example 2.1 .a
150 g (0.407 mol) of N-(3-[(ethoxycarbonyl)amino]-4-fluorobenzoyl)-N'-isopropyl-N'-
methylsulfamide suspended in chlorobenzene were concentrated in a reaction vessel
under reduced pressure (internal temperature broken and the suspension cooled to 65°C. Subsequently, 760 g (5.517 mol) of sulfuryl
chloride were added in portions, in the course of which the temperature was kept at
50°C. Subsequently, the mixture was stirred for a further 16 h.
Excess sulfuryl chloride was then removed by distillation. The distillation residue was
admixed with chlorobenzene and water and cooled to room temperature, and the pH of
the thus obtained suspension was adjusted to pH = 5 using 2N sodium hydroxide
solution. Subsequently, the product was filtered off, washed and dried.
126.5 g (75% of theory) of the title compound were obtained (m.p.: 98-100°C).
Example 2.1 .b
40 g (0.11 mol) of N-{3-[(ethoxycarbonyl)amino]-4-fluorobenzoyl}-N'-isopropyl-N'-
methylsulfamide were added to 179.3 g (1.33 mol) of sulfuryl chloride and stirred at
40°C for 10 h. Excess sulfuryl chloride and chlorobenzene were subsequently removed
by distillation. The residue was admixed at 75°C with stirring initially with toluene, then
with water. At 80-85°C, the pH was adjusted to pH = 4 by means of 2N sodium
hydroxide solution and the mixture was cooled to 20°C with stirring. The precipitated
product was filtered off, washed and dried.
33 g (71% of theory) of the title compound were obtained (m.p.: 98-100°C).
Example 2.2:
N-{2-Chloro-4-fluoro-5-[(methoxycarbonyl)amino]benzoyl}-N'-/sopropyl-N'-
methylsulfamide (Compound II.A.I.b.45)

40 g (0.112 mol) of N-(3-[(methoxycarbonyl)amino]-4-fluorobenzoyl}-N'-isopropyl-N'-
methylsulfamide suspended in chlorobenzene were concentrated in a reaction vessel
under reduced pressure. The vacuum was then broken and the suspension was cooled
to 65°C. Subsequently, 197 g (1.430 mol) of sulfuryl chloride were added in portions, in
the course of which the temperature was kept at 50°C. Subsequently, the mixture was
stirred for a further 16 h.
Excess sulfuryl chloride was then removed by distillation. The distillation residue was
admixed with chlorobenzene and water, and cooled to room temperature, and the pH
of the suspension thus obtained was adjusted to pH = 5 with 2N sodium hydroxide
solution. The product was then filtered off, washed and dried.
14.6 g (34% of theory) of the title compound were obtained.
1H NMR (500 MHz, C1-C4MSO): 8 = 11.1 (s, 1 H), 9.80 (s, 1 H), 7.90-7.95 (m, 1 H), 7.60-
7.70 (m, 1 H), 4.25-4.30 (m, 1 H), 3.80 (s, 3 H), 2.85 (s, 3 H), 1.15 (d, 6 H).
3. Preparation of the phenvl(thio)uracils and -dithiouracils of the formula I
Example 3.1:
2-Chloro-5-r3.6-dihvdro-2,6-dioxo-4-arifluoromethvl)-1(2H)-pyrimidinvn-4-fluoro-N-
(rmethyl(1-methylethvl)amino1sulfonyl)benzamide

Example 3.1 .a
9.13 g (0.049 mol) of ethyl 3-amino-4,4,4-trifluoro-2-butenoate were initially charged in
DMF at room temperature. 12.84 g (0.059 mol) of potassium methoxide solution (32%
in methanol) were added and the mixture was left to stir for a further 30 min.
Subsequently, 20 g (0.049 mol) of N-(2-chloro-4-fluoro-5-[(ethoxycarbonyl)amino]-
benzoyl)-N'-/sopropyl-N'-methylsulfamide were added. The reaction mixture was
heated and sufficient alcohol was distilled off to attain 119°C. While distilling off alcohol,
11.75 g (0.054 mol) of potassium methoxide solution (32% in methanol) were then
added in portions within a few hours. For the work up, the reaction mixture was added
dropwise with cooling to dilute hydrochloric acid, and the pH at the end was precipitated product was filtered off, washed and dried.
22.5 g (92.7% of theory) of the title compound were obtained [m.p. 238°C
(decomposition)].
Example 3.1.b
1.2 g (6.8 mmol) of ethyl 3-amino-4,4,4-trifluoro-2-butenoate were initially charged in
DMF at room temperature. 1.9 g (13.7 mmol) of potassium carbonate were added and
the mixture was left to stir at 50°C for 1 h. Subsequently, 2.4 g (5.7 mmol) of N-(2-
chloro-4-fluoro-5-[(ethoxycarbonyl)amino]benzoyl)-N'-/sopropyl-N'-methylsulfamide
were added, the temperature was increased to 120°C and the mixture was stirred for a
further 4.5 h. For the work up, the reaction mixture was added dropwise with cooling to
dilute hydrochloric acid, and the pH at the end of the reaction was product was filtered off, washed and dried.
2.3 g (73% of theory) of the title compound were obtained.
Example 3.2:
2-Chloro-5-r3,6-dihvdro-3-methvl-2,6-dioxo-4-(trifluoromethvl)-1(2H)-pyrimidinvn-4-
fluoro-N-rrmethvl-(1-methvlethyl)amino1sulfonvnbenzamide

1.14 g (9.04 mmol) of dimethyl sulfate and 0.283 g (2.055 mmol) of K2C03 were added
to 2.0 g (4.11 mmol) of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-
1 (2H)pyrimidinyl-4-fluoro-N-[[methyl(1 -methylethyl)amino]sulfonyl]benzamide from
example 1 in 80 ml of N,N-dimethylformamide, and the mixture was then stirred at
25°C for 16 hours. Subsequently, the N,N-dimethylformamide was distilled off at 30°C
and reduced pressure and the residue was taken up in about 250 ml of ethyl acetate.
The reaction mixture was acidified with 10% HCI and then extracted twice with water.
The organic phase was dried over MgS04 and the solvent was distilled off to obtain
1.95 g of the crude product. According to 1H NMR and HPLC, the purity of the product
of value was 77% (corresponds to a yield of 73%). For purification, 0.92 g of this crude
product was chromatographed on silica gel (28 x 4.5 cm column) with from 9/1 to 1/1
cyclohexane/ethyl acetate to obtain four fractions. The 3rd fraction (0.58 g;
corresponds to 59% isolated yield) comprised the desired product of value in pure
form.
1H NMR data (DMSO-d6) 5 (ppm): 12.2 (NH), 7.8 (d, 1 H), 7.7 (d, 1 H), 6.6 (s, 1 H), 4.1
(sept, 1 H), 3.5 (s, 3 H), 3.3 (s, 3 H), 2.9 (s, 3 H), 1.2 (d, 6 H)
Example 3.3:
2-Ch[oro-5-r3,6-dihvdro-3-methvl-2.6-dioxo-4-(trifluoromethvl)-1(2H)-pyrimidinyl]-4-
fluoro-N-[rmethvl-(1-methvlethyl)amino1sulfonvnbenzamide

12.45 g (0.024 mol) of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-
1 (2H)pyrimidinyl-4-fluoro-N-[[methyl(1 -methylethyl)amino]sulfonyl]benzamide (93.9%
pure) from example 1 were added at 25°C to a solvent mixture of 135 g of toluene and
27 g of tetrahydrofuran, and then the mixture was admixed with a solution of 2.3 g
(0.0288 mol) of sodium hydroxide (50%) in 57.5 g of water. 0.77 g (0.0024 mol) of
tetrabutylammonium bromide and 3.69 g (0.0293 mol) of dimethyl sulfate were added
to the reaction mixture. The biphasic reaction mixture was stirred intensively at 25°C for
23 hours.
The aqueous phase was then removed and the organic phase was washed twice with
100 ml each time of water. After the combined organic phase had been dried, the
solvent was distilled off under reduced pressure to obtain 13.8 g of a crude product
which, by quantitative HPLC, comprised the title compound to an extent of 77.5%
(corresponds to a yield of 88.9%).
Example 3.4:
2-Chloro-5-r3.6-dihvdro-3-methvl-2.6-dioxo-4-(trifluoromethvl)-1(2H)-pyrimidinvn-4-
fluoro-N-rrmethvl-(1-methvlethyl)amino1sulfonvnbenzamide

5 g (10.3 mmol) of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-
1 (2H)pyrimidinyl-4-fluoro-N-[[methyl(1 -methylethyl)amino]sulfonyI]benzamide from
example 1 were added to a solvent mixture of 250 mi of dichloromethane and 125 ml of
tetrahydrofuran and then admixed with a solution of 0.411 g (10.3 mmol) of NaOH in
375 ml of water. 0.38 g (1.03 mmol) of tetrabutylammonium iodide and 1.36 g
(10.8 mmol) of dimethyl sulfate were added to the reaction mixture and the biphasic
mixture was stirred at 1000 revolutions/min for 14 hours.
The aqueous phase was removed and the organic phase was concentrated to dryness
under reduced pressure. The chromatographic purification on silica gel was effected in
the manner described in example 5 to obtain 4 fractions. After the solvent had been
removed, the first fraction comprised 0.54 g of a mixture which, according to 1H NMR,
consisted of the desired product of value to an extent of 90%, and the second fraction 2
comprised 2.4 g of the product of value having a purity of > 95% (yield based on the
two fractions: 56%).
WE CLAIM:
A process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I

where the variables are each defined as follows:
R1 is hydrogen, C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-
cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-
haloalkynyl, phenyl-C1-C4-alkyl or amino,
R2 and R3 are each independently
hydrogen, Ci-Ce-alkyI, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl,
C2-C6-haloalkenyl, C3-C6-alkynyl or C3-C6-haloalkynyl;
X1, X2 and X3 are each independently
oxygen or sulfur;
Ar is phenyl which may be partly or fully halogenated and/or may carry from
one to three radicals from the group of cyano, C1-C4-alkyl or C1-C4-
haloalkyl, and
A is NR4R5 where R4 and R5 are each independently hydrogen or C1-C6-alkyl;
which comprises reacting carbamates of the formula II

where the variables X1, X3, Ar and A are each as defined above and L1 is C1-C6-alkoxy
or C1-C6-alkylthio
with enamines of the formula III

where the variables X2, R1, R2 and R3 are each as defined above and L2 is C1-C6-
alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy,
C1-C4-alkylthio-C2C4-alkoxy, C2-C6-aIkenyloxy, C2-C6-haloalkenyl-oxy,
C3-C6-alkynyloxy, C3-C6-haloalkynyloxy, C3-C8-cycloalkyloxy, C1-C6-
cyanoalkoxy or benzyloxy which in turn may be partially or fully
halogenated on the phenyl ring and/or may be substituted by from
one to three radicals from the group of cyano, nitro, C1-C4-alkyl, d-
C4-alkoxy and C1-C4-alkylthio;
in the presence of an excess of base, such as herein described based on the
carbamate of the formula II.
2. The process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claim 1, wherein R1 is hydrogen or C1-C4-alkyl.
3. The process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claims 1 and 2, wherein R2 is hydrogen, C1-C4-alkyl or C1-C4-
haloalkyl.
4. The process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claims 1 to 3, wherein R3 is hydrogen or C1-C4-alkyl.
5. The process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claims 1 to 4, wherein X1, X2 and X3 are each oxygen.
6. The process as claimed in claims 1 to 5, wherein Ar is a group of the general
formula Ar-1
where
* represents the bond of Ar to the C(X3) group;
** represents the bond of Ar to the directly adjacent nitrogen atom;
Raand Rc are each independently
hydrogen, halogen, cyano or C1-C4-haloalkyl; and
Rb and Rd are each hydrogen.
7. The process as claimed in claims 1 to 6, wherein A is an -NR4R5 group where
the substituents R4 and R5 are each independently hydrogen or C1-C6-alkyl which
may itself be substituted by a substituent selected from the group of
halogen, cyano, C3-C8-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-
alkoxycarbonyl, phenyl which may itself carry from one to three radicals
from the group of halogen or C1-C4-alkoxy;
furyl, thienyl and 1,3-dioxolanyl.
8. The process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claims 1 to 7, wherein the carbamates of the formula II are
prepared by reacting amines of the formula IV

where X3, Ar and A are each as defined under claim 1
with compounds of the formula V

where X1 and L1 are each as defined under claim 1 and
L3 is chlorine or C1-C6-alkoxy.
9. The process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claims 1 to 8, wherein the carbamates of the formula II are
halogenated on the Ar radical with a halogenating agent in an intermediate step.
10. A carbamate of the formula II

where X1, X3, Ar, A and L1 are each as defined under claim 1.
11. A process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claim 1

where R1 is defined as follows:
R1 is C1-C6alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-
alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl, phenyl-C1-C4-
alkyl or amino;
and the variables R2, R3, X1, X2, X3, Ar and A are each as defined in claims 1 to 7,
which comprises reacting carbamates of the formula II

where the variables X1, X3, Ar and A are each as defined above and L1 is C1-C6-alkoxy
or C1-C6-alkylthio
with enamines of the formula III

where R1 is hydrogen, the variables X2, R2 and R3 are each as defined above
and L2 is C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy,
C1-C4-alkylthio-C2C4-alkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy,
C3-C6-alkynyloxy, C3-C6-haloalkynyloxy, C3-C8-cycloalkyloxy, C1-C6-
cyanoalkoxy or benzyloxy which may itself be partly or fully
halogenated on the phenyl ring and/or may be substituted by from
one to three radicals from the group of cyano, nitro, C1-C4-alkyl, C1-
C4-alkoxy and C1-C4-alkylthio;
and then reacting the resulting 3-phenyl(thio)uracil and -dithiouracil of the
formula I where R1 is hydrogen,
with an alkylating agent of the formula VI
R1—L4 VI
where R1 is C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyl, C3-C8-
cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-
haloalkynyl or phenyl-C1-C4-alkyl; and
L4 is halogen, hydrogensulfate, C1-C6-alkylsulfate, sulfate, C1-C6-
alkylsulfonyloxy, C1-C6-haloalkylsulfonyloxy or phenylsulfonyloxy
where the phenyl ring is optionally mono- or polysubstituted by
halogen, nitro, C1-C6-alkyl or C1-C6-haloalkyl;
to give 3-phenyl(thio) uracils and -dithiouracils of the formula I
where R1 is C1-C6-aIkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyI, C3-C8-
cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-
haloalkynyl or phenyl-C1-C4-alkyl;
or
with an aminating agent of the formula VII
H2N—L5 VII
where L5 is halogen, hydrogensulfate, C1-C6-alkylsulfonyloxy, C1-C6-
haloalkylsulfonyloxy, phenylsulfonyloxy or phenyloxy, where the phenyl
ring is optionally mono- or polysubstituted by halogen, nitro, C1-C6-alkyl or
Ci-Ce-haloalkyI
to give 3-phenyl(thio)uracils and -dithiouracils of the formula I where R1 is
NH2.
12. A process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claim 11 where R1 is C1-C6-alkyl or amino.
13. A process for preparing 3-phenyl(thio)uracils and -dithiouracils of the formula I
as claimed in claim 11 where R1 is C1-C6-alkyl.


The instant invention discloses a process for preparing 3-phenyl(thio)uracils and -
dithiouracils of the formula I where the variables are each defined as follows:
R1 is hydrogen, C1-C6-alkyl, C1-C4-cyanoalkyl, C1-C6-haloalkyI, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-
haloalkynyl, phenyl-C1-C4-alkyl or amino,
R2 and R3 are each independently hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl or C3-C6-haloalkynyl; X1, X2 and X3 are each independently oxygen or sulfur;
Ar is phenyl which may be partly or fully halogenated and/or may carry from
one to three radicals from the group of cyano, C1-C4-alkyl or C1-C4-haloalkyl, and A is NR4R5 where R4 and R5 are each independently hydrogen or C1-C6-alkyl; which comprises reacting carbamates of the formula II where the variables X1, X3, Ar and A are each as defined above and L1 is C1-C6-alkoxy or C1-C6-alkylthio with enamines of the formula III where the variables X2, R1, R2 and R3 are each as defined above and L2 is C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C4-alkoxy-C2-C4-alkoxy, C1-C4-alkylthio-C2C4-alkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyl-oxy,
C3-C6-alkynyloxy, C3-C6-haloalkynyloxy, C3-C8-cycloalkyloxy, C1-C6-cyanoalkoxy or benzyloxy which in turn may be partially or fully
halogenated on the phenyl ring and/or may be substituted by from one to three radicals from the group of cyano, nitro, C1-C4-alkyl, C1-
C4-alkoxy and C1-C4-alkylthio; in the presence of an excess of base, such as herein described based on the carbamate of the formula II.

Documents:

03861-kolnp-2006 abstract.pdf

03861-kolnp-2006 claims.pdf

03861-kolnp-2006 correspondence others.pdf

03861-kolnp-2006 description(complete).pdf

03861-kolnp-2006 form-1.pdf

03861-kolnp-2006 form-3.pdf

03861-kolnp-2006 form-5.pdf

03861-kolnp-2006 others.pdf

03861-kolnp-2006 pct other.pdf

03861-kolnp-2006 priority document.pdf

03861-kolnp-2006-correspondence-1.1.pdf

03861-kolnp-2006-correspondence-1.2.pdf

03861-kolnp-2006-form-18.pdf

03861-kolnp-2006-form-5-1.1.pdf

3861-kolnp-2006-abstract.pdf

3861-kolnp-2006-claims.pdf

3861-KOLNP-2006-CORRESPONDENCE 1.1.pdf

3861-KOLNP-2006-CORRESPONDENCE 1.2.pdf

3861-kolnp-2006-correspondence1.3.pdf

3861-kolnp-2006-description (complete).pdf

3861-kolnp-2006-examination report.pdf

3861-kolnp-2006-form 1.pdf

3861-kolnp-2006-form 18.pdf

3861-kolnp-2006-form 3.pdf

3861-kolnp-2006-form 5.pdf

3861-KOLNP-2006-FORM-27.pdf

3861-kolnp-2006-gpa.pdf

3861-KOLNP-2006-INTERNATIONAL SEARCH REPORT.pdf

3861-kolnp-2006-reply to examination report.pdf

3861-kolnp-2006-specification.pdf

3861-kolnp-2006-translated copy of priority document.pdf

abstract-03861-kolnp-2006.jpg


Patent Number 243850
Indian Patent Application Number 3861/KOLNP/2006
PG Journal Number 46/2010
Publication Date 12-Nov-2010
Grant Date 09-Nov-2010
Date of Filing 20-Dec-2006
Name of Patentee BASF AKTIENGESELLSCHAFT
Applicant Address 67056 LUDWIGSHAFEN
Inventors:
# Inventor's Name Inventor's Address
1 LOHR, SANDRA BENCKISER STR, 30, 67059 LUDWIGSHAFEN
2 MAYER GUIDO PAUL-MUNCH-WEG 7, 67161 GONNHEIM
3 KEIL MICHAEL FONTANESTR. 4, 67251 FREINSHEIM
4 SCHMIDT, THOMAS PFARRGASSE 8, 67433 NEUSTADT
5 WOLF BERND HALBERGSTR 4, 67136 FUSSGONHEIM
6 GEBHARDT JOACHIM PEGAUER STR. 51,67157 WACHENHEIM
PCT International Classification Number N/A
PCT International Application Number PCT/EP2005/007577
PCT International Filing date 2005-07-13
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 10 2004 035 656.4 2004-07-22 Germany